Dental curable composition

A dental curable composition with a hydrophilic and hydrophobic polymerization initiator improves adhesive strength to dentin by balancing penetration and curing, addressing the inadequacies of existing compositions.

WO2026240206A1PCT designated stage Publication Date: 2026-11-19KURARAY NORITAKE DENTAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/JP2026/018492
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-05-15
Filing Date
2026-05-15
Publication Date
2026-11-19

AI Technical Summary

Technical Problem

Existing dental adhesive compositions exhibit inadequate adhesive strength to dentin, which is necessary for dental restorative materials.

Method used

A dental curable composition containing a polymerization initiator with both hydrophilic and hydrophobic properties, represented by specific general formulas, enhances adhesive strength to dentin by facilitating penetration and curing within the dentin structure.

Benefits of technology

The composition achieves high adhesive strength to dentin, forming a strong resin-impregnated layer due to the amphiphilicity of the polymerization initiator, which balances hydrophilicity and hydrophobicity for effective bonding.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure JP2026018492_19112026_PF_FP_ABST
    Figure JP2026018492_19112026_PF_FP_ABST
Patent Text Reader

Abstract

This dental curable composition comprises a polymerization initiator represented by general formula (1). (In general formula (1), the meaning of each symbol is as defined in the description.)
Need to check novelty before this filing date? Find Prior Art

Description

dental curable composition

[0001] This invention relates to a dental curable composition.

[0002] For the treatment of tooth structure defects caused by caries or fracture, filling and restorative materials such as dental composite resins, and crown restorative materials such as metal alloys, ceramics, and resin materials are widely used. Dental bonding agents are mainly used to bond filling and restorative materials to tooth structure, and dental cements are mainly used to bond crown restorative materials to tooth structure. Among these dental restorative materials, resin-based curable compositions are commonly used.

[0003] A commonly used adhesive system employing dental bonding materials involves applying a bonding material and then applying a dental restorative material on top of it to bond the tooth structure to the restorative material. This restoration method uses two materials: dental bonding material and dental filling material (dental composite resin). In recent years, however, self-adhesive dental composite resins have been developed, which provide adhesive properties to dental filling composite resins. These are beginning to be put into practical use as materials that eliminate the need for dental bonding material, reducing the number of steps in restorative treatment.

[0004] Traditionally, dental cements have typically used a system involving a pretreatment material (primer or bonding agent) and a two-paste type dental cement. This system is called pretreatment-assisted dental cement. In this system, before bonding the crown material to the tooth structure, a pretreatment material containing adhesive monomers is used to simultaneously remove the smear layer on the tooth surface and allow the monomers to penetrate the collagen layer. Subsequently, the tooth structure, now permeated with the monomers, and the prosthesis are bonded by hardening the dental cement. In recent years, in order to expedite dental treatment and reduce the burden on patients, there has been a demand for simplification of dental treatment procedures. As a result, self-adhesive dental cements that can bond tooth structure and prostheses without the use of pretreatment materials—that is, cements that can perform demineralization, penetration, and hardening all at once—have become widespread.

[0005] Dental curing compositions used for bonding to substrates such as dental filling composite resins, dental cements, dental bonding materials, dental self-adhesive composite resins, and dental self-adhesive cements are required to exhibit excellent adhesive strength to the substrate.

[0006] For example, Patent Document 1 discloses a non-solvent dental adhesive composition that exhibits high initial adhesion strength and adhesive durability to tooth structure and substantially does not contain water or organic solvents, and contains an acidic group-containing polymerizable monomer, a hydrophobic polymerizable monomer without an acidic group, and a specific photopolymerization initiator.

[0007] International Publication No. 2020 / 179852

[0008] However, when the present inventors used the dental adhesive composition described in Patent Document 1, it was found that there is room for improvement in the adhesive strength to dentin, which is necessary for dental restorative materials.

[0009] Therefore, the present invention aims to provide a dental curable composition having high adhesive strength to dentin.

[0010] As a result of diligent research, the inventors of the present invention have found that a dental curable composition containing a polymerization initiator possessing both hydrophilic and hydrophobic properties can solve the above problems, and have completed the present invention through further research. That is, the present invention encompasses the following invention: [1] A dental curable composition comprising a polymerization initiator (A) and a polymerizable monomer (B) represented by the following general formula (1). (In the formula, R 1 ~R 8 Each of these is independently an organic group (s1) containing a hydrogen atom, a linear or branched alkyl group having 1 to 20 carbon atoms, a linear or branched alkoxy group having 1 to 20 carbon atoms, a halogen atom, or a site to which two or more carbon atoms are linearly bonded and two or more hydroxyl groups, R 1 ~R 8 Of these, at least one is an organic group (s1) that includes a site in which two or more carbon atoms are bonded in a linear chain and two or more hydroxyl groups.) [2] R in the general formula (1) 1is the aforementioned organic group (s1), and R 2 to R 8 are each independently a hydrogen atom, a linear or branched alkyl group having 1 to 20 carbon atoms, a linear or branched alkoxy group having 1 to 20 carbon atoms, or a halogen atom, the dental curable composition according to the above [1]. [3] The dental curable composition according to the above [2], wherein the polymerization initiator (A) is a compound represented by the following general formula (2). (In the formula, R 1a is an organic group (s1) containing a site where 2 or more carbon atoms are linearly bonded and 2 or more hydroxyl groups.) [4] The dental curable composition according to any one of the above [1] to [3], wherein the organic group (s1) is represented by the following general formula (3). (In the formula, X is -C(=O)-O-, -C(=O)-NH- or -C(=O)-. Y is a group containing a hydrocarbon group (s2) having 2 to 20 carbon atoms and 2 or more hydroxyl groups. * represents a bonding site.) [5] The dental curable composition according to the above [4], wherein the organic group (s1) is a group represented by the following general formula (4-1). (In the formula, n 1 is an integer of 1 to 10. * represents a bonding site.) [6] The dental curable composition according to any one of the above [1] to [4], wherein the organic group (s1) is a group containing a 5-membered ring having 2 or more hydroxyl groups or a 6-membered ring structure having 2 or more hydroxyl groups. [7] The dental curable composition according to the above [6], wherein the group containing a 5-membered ring having 2 or more hydroxyl groups or a 6-membered ring structure having 2 or more hydroxyl groups is a group represented by the following general formula (5-1). (In the formula, n 1(where is an integer from 1 to 10. * is a bonding site.) [8] The dental curable composition according to any one of [1] to [7] above, wherein the polymerizable monomer (B) comprises a bifunctional monomer. [9] The dental curable composition according to any one of [1] to [8] above, wherein the polymerizable monomer (B) comprises a polymerizable monomer (B-1) having an acidic group.

[10] The dental curable composition according to any one of [1] to [9] above, further comprising an organic amine compound (C).

[11] The dental curable composition according to any one of [1] to

[10] above, which is a dental bonding material, a dental filling composite resin, or a dental cement.

[12] The dental curable composition according to

[11] above, wherein the dental filling composite resin is a dental self-adhesive composite resin, and the dental cement is a dental self-adhesive cement.

[0011] According to the present invention, it is possible to provide a dental curable composition having high adhesive strength to dentin.

[0012] The present invention will be described in detail below using embodiments. In this specification, the upper and lower limits of numerical ranges (content of each component, values ​​calculated from each component, and each physical property, etc.) can be combined as appropriate. Similarly, in this specification, the numerical values ​​of each symbol in the formulas can also be combined as appropriate. That is, in this specification, the lower and upper limits of numerical ranges described in steps can be combined independently. For example, from the description "preferably 10 to 90, more preferably 30 to 60" for the same item, the "preferred lower limit (10)" and the "more preferred upper limit (60)" can be combined to get "10 to 60". Regarding numerical ranges, for example, based on the description "preferably 10 to 90, more preferably 30 to 60", the upper limit can be not specifically specified, and only the lower limit can be specified as "10 or more" or "30 or more", and similarly, the lower limit can be not specifically specified, and only the upper limit can be specified as "90 or less" or "60 or less". Unless otherwise specified, a numerical range, for example, simply written as "10 to 90," represents the range of 10 to 90. Similarly, for example, from descriptions such as "preferably 10 or more, more preferably 30 or more" and "preferably 90 or less, more preferably 60 or less" for the same item, the "preferred lower limit (10)" and the "more preferred upper limit (60)" can be combined to result in "10 or more and 60 or less." Also, similarly, only the lower limit can be specified as "10 or more" or "30 or more," and similarly, only the lower limit can be specified as "90 or less" or "60 or less."

[0013] In the present specification, the expression "(meth)acryl" is used to encompass both "methacryl" and "acryl". The same applies to similar expressions such as "(meth)acrylate", "(meth)acrylic acid ester", "(meth)acrylamide", and "(meth)acryloyloxy". In the present specification, the expression "carboxylic acid group" is used to encompass both "carboxy group" and "acid anhydride group", and the aforementioned "acid anhydride group" refers to a functional group formed by dehydration condensation of one water molecule from two carboxy groups. In the present specification, "monofunctional" refers to having one radically polymerizable functional group per molecule, such as a vinyl group, allyl group, acryloyl group, methacryloyl group, acrylamide group, and methacrylamide group. Similarly, in the present specification, "polyfunctional" refers to having a plurality of the aforementioned radically polymerizable functional groups per molecule, "difunctional" refers to having two of the aforementioned radically polymerizable functional groups per molecule, and "trifunctional or higher" refers to having three or more of the aforementioned radically polymerizable functional groups per molecule. In these cases, the plurality of the aforementioned radically polymerizable functional groups present in one molecule may each be the same or different.

[0014] [Dental Curable Composition] The dental curable composition according to one aspect of the present invention (herein also simply referred to as "the aforementioned dental composition") is a dental curable composition comprising a polymerization initiator (A) represented by the following general formula (1) and a polymerizable monomer (B).

[0015] (wherein R 1 to R 8 each independently represent a hydrogen atom, a linear or branched alkyl group having 1 to 20 carbon atoms, a linear or branched alkoxy group having 1 to 20 carbon atoms, a halogen atom, or an organic group (s1) containing a site where two or more carbon atoms are linearly bonded and two or more hydroxyl groups, and at least one of R 1 to R 8 is the organic group (s1) containing a site where two or more carbon atoms are linearly bonded and two or more hydroxyl groups.)

[0016] The reason why the aforementioned curable dental composition has high adhesive strength to dentin is not entirely clear, but is presumed as follows. Actions required to obtain adhesive strength to dentin with a curable dental composition include a "demineralization action" that dissolves the dentin surface with an acidic component, a "penetration action" that allows the monomer component to penetrate into the collagen layer of dentin, and a "curing action" that cures the penetrated monomer component to form a hybrid layer with collagen (hereinafter sometimes referred to as "resin-impregnated layer"). Among these factors, enhancing the curability of the resin-impregnated layer is extremely important for improving adhesiveness. The polymerization initiator (A) contained in the aforementioned curable dental composition is represented by the aforementioned general formula (1), and has an organic group (s1) containing a site where two or more carbon atoms are bonded in a straight chain and two or more hydroxyl groups (hereinafter sometimes simply referred to as "organic group (s1)"). The organic group (s1) has amphiphilicity, as it contains two or more hydrophilic hydroxyl groups and a site where two or more hydrophobic carbon atoms are bonded in a straight chain. Since dental tissue, particularly dentin, contains moisture, its surface is hydrophilic. Therefore, the polymerization initiator (A), whose hydrophilicity is enhanced by the organic group (s1) having two or more hydroxyl groups, is considered to easily penetrate into dentin at the adhesion interface. In addition, since the polymerization initiator (A) has the hydrophobic portion of the organic group (s1), it has excellent affinity for hydrophobic monomer components, and is considered to penetrate into dentin together with these monomer components. It is presumed that by photocuring this, a strong resin-impregnated layer is formed, and as a result, the aforementioned curable dental composition exhibits high adhesive strength to dentin.

[0017] Hereinafter, each component used in the curable dental composition which is one aspect of the present invention will be described.

[0018] <Polymerization Initiator (A)> The dental curable composition contains a polymerization initiator (A) represented by the following general formula (1). By containing the polymerization initiator (A), the dental curable composition has the high adhesive strength to dentin necessary for dental restorative materials. The polymerization initiator (A) functions as a radical generator that generates radicals by irradiation with light in at least one region selected from the visible light region and the near-ultraviolet region. The polymerization initiator (A) may be used alone or in combination of two or more types.

[0019] (In the formula, R 1 ~R 8 Each of these is independently an organic group (s1) containing a hydrogen atom, a linear or branched alkyl group having 1 to 20 carbon atoms, a linear or branched alkoxy group having 1 to 20 carbon atoms, a halogen atom, or a site to which two or more carbon atoms are linearly bonded and two or more hydroxyl groups, R 1 ~R 8 Of these, at least one is an organic group (s1) containing a site where two or more carbon atoms are bonded in a linear chain and two or more hydroxyl groups.

[0020] In the above general formula (1), R 1 ~R 8 Of these, at least one is an organic group (s1), and at least R 1 It is preferable that is an organic group (s1), R 1 is an organic group (s1), R 2 ~R 8 However, it is more preferable that each of them independently be a hydrogen atom, a linear or branched alkyl group having 1 to 20 carbon atoms, a linear or branched alkoxy group having 1 to 20 carbon atoms, or a halogen atom.

[0021] In the above general formula (1), R 1 ~R 8 Of these, the group that is not an organic group (s1) is preferably a hydrogen atom or a linear or branched alkyl group having 1 to 20 carbon atoms.

[0022] In the above general formula (1), R 1 ~R 8Examples of linear or branched alkyl groups having 1 to 20 carbon atoms represented by R include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, and eicosyl groups. If these alkyl groups can take the form of n-, sec-, tert-, or iso-, any of these forms is acceptable. Among these, R 1 ~R 8 The linear or branched alkyl group having 1 to 20 carbon atoms represented by is preferably a methyl group, ethyl group, propyl group, butyl group, pentyl group, hexyl group, heptyl group, octyl group, nonyl group, or decyl group, more preferably a methyl group, ethyl group, propyl group, butyl group, or pentyl group, even more preferably a methyl group, ethyl group, or propyl group, and even more preferably a methyl group or ethyl group. 1 ~R 8 The number of carbon atoms in the linear or branched alkyl group having 1 to 20 carbon atoms represented by is preferably 1 to 10, more preferably 1 to 5, even more preferably 1 to 3, and even more preferably 1 or 2.

[0023] In the above general formula (1), R 1 ~R 8 Examples of alkyl groups included in the linear or branched alkoxy group having 1 to 20 carbon atoms represented by include the same ones as the linear or branched alkyl groups having 1 to 20 carbon atoms mentioned above.

[0024] The polymerization initiator (A) represented by the general formula (1) is preferably a compound represented by the general formula (2) below.

[0025] (In the formula, R 1a This is an organic group (s1) containing a site where two or more carbon atoms are bonded in a linear chain and two or more hydroxyl groups.

[0026] In the above general formula (1), R 1 ~R 8 and R in the general formula (2) 1aThe "site where two or more carbon atoms are bonded in a linear chain" in the organic group (s1) represented by means of a site that includes at least the structure represented by the following formula (s1-1) (two carbon atoms bonded by a single bond), the structure represented by the following formula (s1-2) (two carbon atoms bonded by a double bond), or the structure represented by the following formula (s1-3) (two carbon atoms bonded by a triple bond).

[0027] (In each formula, * represents a bonding site to another atom.)

[0028] The more carbon atoms in the linearly linked region of the organic group (s1), the higher the hydrophobicity and affinity with the monomer component, thus enabling the creation of a strong resin-impregnated layer within the dentin. On the other hand, the fewer carbon atoms there are, the higher the hydrophilicity and penetration into the dentin. Therefore, a balance between hydrophobicity and hydrophilicity is important to further enhance the adhesive strength to the dentin. From this viewpoint, the number of carbon atoms is preferably 2 to 20, more preferably 3 to 15, even more preferably 4 to 10, and even more preferably 4 to 8. Note that if the organic group (s1) includes a region where three or more carbon atoms are linked in a branched chain, this region may contain multiple "regions where two or more carbon atoms are linked in a linear chain." For example, the branched hydrocarbon group represented by the following formula (s1-4) includes the following three types of "regions where two or more carbon atoms are linked in a linear chain": (1)-C 1 -C 2 -C 3 -C 4 - (A site where four carbon atoms are bonded in a linear chain) (2)-C 5 -C 2 -C 3 -C 4 - (A site where four carbon atoms are bonded in a linear chain) (3)-C 1 -C 2 -C 5 - (A site where three carbon atoms are bonded in a linear chain)

[0029] (In the formula, * represents a bonding site to an atom other than a carbon atom.)

[0030] The number of hydroxyl groups contained in the organic group (s1) is two or more, preferably 2 to 8, more preferably 2 to 6, and even more preferably 2 to 4, from the viewpoint of improving the adhesive strength to dentin by balancing hydrophobicity and hydrophilicity.

[0031] The number of carbon atoms in the organic group (s1) is preferably 3 to 25, more preferably 4 to 20, even more preferably 5 to 15, and even more preferably 6 to 10, from the viewpoint of improving the adhesive strength to dentin by balancing hydrophobicity and hydrophilicity.

[0032] The organic group (s1) is more preferably a group containing an oxygen atom (excluding oxygen atoms contained in a hydroxyl group) or a nitrogen atom, and more preferably a group represented by the following general formula (3).

[0033] (In the formula, X is -C(=O)-O-, -C(=O)-NH-, or -C(=O)-. Y is a group containing a hydrocarbon group (s2) having 2 to 20 carbon atoms and two or more hydroxyl groups. * indicates a bonding site.)

[0034] The hydrocarbon group (s2) having two or more hydroxyl groups in Y in the general formula (3) and having 2 to 20 carbon atoms (hereinafter sometimes simply referred to as "hydrocarbon group (s2)") may be a monovalent hydrocarbon group or a divalent hydrocarbon group. The number of carbon atoms in the hydrocarbon group (s2) is preferably 2 to 20, more preferably 3 to 15, even more preferably 4 to 10, and even more preferably 5 to 8, from the viewpoint of improving the adhesive strength to dentin by balancing hydrophobicity and hydrophilicity. The hydrocarbon group (s2) may be linear, branched, or cyclic. The hydrocarbon group (s2) may be an aliphatic hydrocarbon group or an aromatic hydrocarbon group, but it is preferably an aliphatic hydrocarbon group, and more preferably a saturated aliphatic hydrocarbon group. The hydrocarbon group (s2) may be directly bonded to X in the general formula (3), or it may be bonded via another group. One way in which the hydrocarbon group (s2) is bonded to X in the general formula (3) via another group is, for example, when the hydrocarbon group (s2) is -(CH 2 )n 1-O- group (n 1 The integer is between 1 and 10. Examples include: a configuration in which a hydrocarbon group (s2) is bonded to X via a tertiary nitrogen atom; and so on.

[0035] The overall structure of the organic group (s1) may be a chain-like organic group or an organic group containing a ring structure.

[0036] The chain-like organic group (s1) represented by the general formula (3) above preferably has an ester bond or an amide bond, from the viewpoint of increasing affinity with dentin. For example, a group represented by any of the following general formulas (4-1) to (4-5) can be cited. Among these, the group represented by the following general formula (4-1) is preferred.

[0037] (In the formula, n 1 (where * is an integer between 1 and 10. * indicates a connection point.)

[0038] n in the above general formulas (4-1) to (4-4) 1 Each of these is an integer between 1 and 10, and may be, for example, an integer between 1 and 8, an integer between 2 and 7, or an integer between 3 and 6.

[0039] The organic group (s1) may include a ring structure. If the organic group (s1) includes a ring structure, the ring-forming atoms that form the ring may consist only of carbon atoms, or of carbon atoms and heteroatoms. Note that ring-forming atoms refer to the atoms that constitute the ring itself in a structure in which atoms are bonded in a ring, and do not include hydrogen atoms and substituents that are bonded to the atoms that constitute the ring. A heteroatom means an atom other than a hydrogen atom and a carbon atom, and is preferably a nitrogen atom or an oxygen atom. From the viewpoint of balancing hydrophobicity and hydrophilicity, the ring structure included in the organic group (s1) is preferably a five-membered ring having two or more hydroxyl groups or a six-membered ring having two or more hydroxyl groups. More preferably, the ring structure is a five-membered or six-membered ring structure containing only one heteroatom as a ring-forming atom, with the rest being carbon atoms; even more preferably, it is a five-membered or six-membered ring structure containing only one oxygen atom or nitrogen atom as a ring-forming atom, with the rest being carbon atoms. If the ring structure of the organic group (s1) includes a nitrogen atom as a ring-forming atom, the tertiary nitrogen atom bonded to X in the group represented by the general formula (3) may be the nitrogen atom that is a ring-forming atom.

[0040] Examples of the ring-structured organic group (s1) represented by the general formula (3) include the group represented by any of the following general formulas (5-1) to (5-4). Among these, the group represented by the following general formula (5-1) is preferred.

[0041] (In each formula, n 1 (where * is an integer between 1 and 10. * indicates a connection point.)

[0042] n in the above general formulas (5-1) to (5-2) 1 Each of these is an integer between 1 and 10, and may be, for example, an integer between 1 and 8, an integer between 1 and 5, or an integer between 1 and 3.

[0043] The polymerization initiator (A) represented by the general formula (1) can be synthesized according to known methods. Examples of known methods include: a synthesis method to obtain the target compound by performing an esterification reaction using a camphorquinone derivative having a carboxyl group and a polyhydric alcohol compound having a plurality of hydroxyl groups, of which at least some or all of the remaining hydroxyl groups except at least one are protected, and then subjecting the obtained esterification product to a deprotection treatment of the protected hydroxyl groups; and a synthesis method to obtain the target compound by performing an amidation reaction using a camphorquinone derivative having a carboxyl group and a polyhydric amine compound having a plurality of hydroxyl groups, of which at least some or all of the hydroxyl groups are protected, and then subjecting the obtained amidation product to a deprotection treatment of the protected hydroxyl groups.

[0044] Specific examples of polymerization initiators (A) include compounds represented by the following general formulas (6-1) to (6-5) and (7-1) to (7-4).

[0045]

[0046] n in the above general formulas (6-1) to (6-4) 1 Each of these is an integer between 1 and 10, and may be, for example, an integer between 1 and 8, an integer between 2 and 7, or an integer between 3 and 6.

[0047]

[0048] n in the above general formulas (7-1) to (7-2) 1 Each of these is an integer between 1 and 10, and may be, for example, an integer between 1 and 8, an integer between 1 and 5, or an integer between 1 and 3.

[0049] In the dental curable composition, the content of the polymerization initiator (A) is not particularly limited. In the dental curable composition, from the viewpoint of increasing the adhesive strength to dentin by promoting polymerization, the content of the polymerization initiator (A) is preferably 0.001 to 10 parts by mass, more preferably 0.005 to 5 parts by mass, even more preferably 0.01 to 3 parts by mass, and even more preferably 0.05 to 3 parts by mass, based on 100 parts by mass of the total polymerizable monomers (B) contained in the dental curable composition. Furthermore, the content of the polymerization initiator (A) may be, for example, 0.1 to 3 parts by mass or 0.5 to 3 parts by mass, based on 100 parts by mass of the total polymerizable monomers (B) contained in the dental curable composition. In one embodiment where the dental curable composition is a dental bonding material, from the viewpoint of increasing the adhesive strength to dentin by promoting polymerization, the content of the polymerization initiator (A) is preferably 0.1 to 10 parts by mass, more preferably 0.3 to 5 parts by mass, even more preferably 0.4 to 4 parts by mass, and even more preferably 0.5 to 3 parts by mass, based on 100 parts by mass of the total polymerizable monomers (B) contained in the dental curable composition. In one embodiment where the dental curable composition is a dental cement or a dental filling composite resin, from the viewpoint of increasing the adhesive strength to dentin by promoting polymerization, the content of the polymerization initiator (A) is preferably 0.001 to 3 parts by mass, more preferably 0.005 to 1 part by mass, and even more preferably 0.01 to 0.5 parts by mass, based on 100 parts by mass of the total polymerizable monomers (B) contained in the dental curable composition.

[0050] <Polymerization Initiator (A')> The dental curable composition may contain polymerization initiator (A') other than polymerization initiator (A) from the viewpoint of curability, or it may not contain polymerization initiator (A'). Polymerization initiator (A') may be used alone or in combination of two or more types.

[0051] As the polymerization initiator (A'), known polymerization initiators can be used, for example, photopolymerization initiators other than polymerization initiator (A) (A'-1) (hereinafter sometimes simply referred to as "photopolymerization initiator (A'-1)"), chemical polymerization initiators other than polymerization initiator (A) (A'-2) (hereinafter sometimes simply referred to as "chemical polymerization initiator (A'-2)"), etc.

[0052] • Photopolymerization initiator (A'-1) Examples of photopolymerization initiators (A'-1) include (bis)acylphosphine oxides, thioxanthones, ketals, α-diketones, coumarins, anthraquinones, benzoin alkyl ether compounds, and α-aminoketone compounds.

[0053] Examples of (bis)acylphosphine oxides include 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 2,6-dimethoxybenzoyldiphenylphosphine oxide, 2,6-dichlorobenzoyldiphenylphosphine oxide, 2,4,6-trimethylbenzoylmethoxyphenylphosphine oxide, 2,4,6-trimethylbenzoylethoxyphenylphosphine oxide, 2,3,5,6-tetramethylbenzoyldiphenylphosphine oxide, and benzoyldi(2,6-dimethylphenyl)phosphonate. Examples of bis(2,6-dichlorobenzoyl)phenylphosphine oxides include bis(2,6-dichlorobenzoyl)phenylphosphine oxide, bis(2,6-dichlorobenzoyl)-2,5-dimethylphenylphosphine oxide, bis(2,6-dichlorobenzoyl)-4-propylphenylphosphine oxide, bis(2,6-dichlorobenzoyl)-1-naphthylphosphine oxide, bis(2,6-dimethoxybenzoyl)phenylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentylphosphine oxide, bis(2,6-dimethoxybenzoyl)-2,5-dimethylphenylphosphine oxide, bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide, bis(2,5,6-trimethylbenzoyl)-2,4,4-trimethylpentylphosphine oxide, and sodium bis(2,4,6-trimethylbenzoyl)phosphinate.

[0054] Examples of thioxanthones include thioxanthone and 2-chlorothioxanthene-9-one.

[0055] Examples of ketals include benzyldimethyl ketal and benzyldiethyl ketal.

[0056] Examples of α-diketones include diacetyl, benzyl, dl-camphorquinone, 2,3-pentadione, 2,3-octadione, 9,10-phenanthrenequinone, 4,4'-oxybenzyl, and acenaphthenequinone. Among these, dl-camphorquinone is preferred from the viewpoint of having a maximum absorption wavelength in the visible light range.

[0057] Examples of coumarins include 3,3'-carbonylbis(7-diethylaminocoumarin), 3-(4-methoxybenzoyl)coumarin, 3-thienoylcoumarin, 3-benzoyl-5,7-dimethoxycoumarin, 3-benzoyl-7-methoxycoumarin, 3-benzoyl-6-methoxycoumarin, 3-benzoyl-8-methoxycoumarin, 3-benzoylcoumarin, 7-methoxy-3-(p-nitrobenzoyl)coumarin, 3-(p-nitrobenzoyl)coumarin, 3,5-carbonylbis(7-methoxycoumarin), and 3-benzoyl-6-bromocuma. Phosphorus, 3,3'-carbonylbiscoumarin, 3-benzoyl-7-dimethylaminocoumarin, 3-benzoylbenzo[f]coumarin, 3-carboxycoumarin, 3-carboxy-7-methoxycoumarin, 3-ethoxycarbonyl-6-methoxycoumarin, 3-ethoxycarbonyl-8-methoxycoumarin, 3-acetylbenzo[f]coumarin, 3-benzoyl-6-nitrocoumarin, 3-benzoyl-7-diethylaminocoumarin, 7-dimethylamino-3-(4-methoxybenzoyl)coumarin, 7-diethylamino-3-(4-methoxybenzoyl) Coumarin, 7-diethylamino-3-(4-diethylamino)coumarin, 7-methoxy-3-(4-methoxybenzoyl)coumarin, 3-(4-nitrobenzoyl)benzo[f]coumarin, 3-(4-ethoxycinnamoyl)-7-methoxycoumarin, 3-(4-dimethylaminocinnamoyl)coumarin, 3-(4-diphenylaminocinnamoyl)coumarin, 3-[(3-dimethylbenzothiazole-2-ylidene)acetyl]coumarin, 3-[(1-methylnaphtho[1,2-d]thiazole-2-ylidene)acetyl]coumarin, 3,3'-carbony Rubis(6-methoxycoumarin), 3,3'-carbonylbis(7-acetoxycoumarin), 3,3'-carbonylbis(7-dimethylaminocoumarin), 3-(2-benzothiazolyl)-7-(diethylamino)coumarin, 3-(2-benzothiazolyl)-7-(dibutylamino)coumarin, 3-(2-benzimidazolyl)-7-(diethylamino)coumarin, 3-(2-benzothiazolyl)-7-(dioctylamino)coumarin, 3-acetyl-7-(dimethylamino)coumarin, 3,3'-carbonylbis(7-dibutylaminocoumarin), 3,Examples include compounds described in Japanese Patent Publication No. 9-3109 and Japanese Patent Publication No. 10-245525, such as 3'-carbonyl-7-diethylaminocoumarin-7'-bis(butoxyethyl)aminocoumarin, 10-[3-[4-(dimethylamino)phenyl]-1-oxo-2-propenyl]-2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinoridine-11-one, and 10-(2-benzothiazolyl)-2,3,6,7-tetrahydro-1,1,7,7-tetramethyl-1H,5H,11H-[1]benzopyrano[6,7,8-ij]quinoridine-11-one. Among the aforementioned coumarins, 3,3'-carbonylbis(7-diethylaminocoumarin) and 3,3'-carbonylbis(7-dibutylaminocoumarin) are preferred.

[0058] Examples of anthraquinones include anthraquinone, 1-chloroanthraquinone, 2-chloroanthraquinone, 1-bromoanthraquinone, 1,2-benzanthraquinone, 1-methylanthraquinone, 2-ethylanthraquinone, and 1-hydroxyanthraquinone.

[0059] Examples of benzoin alkyl ether compounds include benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, and benzoin isobutyl ether.

[0060] Examples of α-aminoketone compounds include 2-methyl-1-[4-(methylthio)phenyl]-2-morpholinopropan-1-one.

[0061] Among these photopolymerization initiators (A'-1), it is preferable to use at least one selected from the group consisting of (bis)acylphosphine oxides, α-diketones, and coumarins. This results in a dental curable composition that exhibits excellent photocurability in the visible and near-ultraviolet regions and sufficient photocurability regardless of whether a halogen lamp, light-emitting diode (LED), or xenon lamp is used as the light source.

[0062] If the dental curable composition contains a photopolymerization initiator (A'-1), the amount of the photopolymerization initiator (A'-1) is not particularly limited, but from the viewpoint of the curability of the dental curable composition, it is preferably 0.001 to 10 parts by mass, more preferably 0.01 to 7 parts by mass, and even more preferably 0.1 to 5 parts by mass, based on 100 parts by mass of the total polymerizable monomer (B) contained in the dental curable composition. Depending on the embodiment, the dental curable composition may not contain the photopolymerization initiator (A'-1).

[0063] - Chemical polymerization initiator (A'-2) The dental curable composition may further contain a chemical polymerization initiator (A'-2) from the viewpoint of enabling chemical polymerization and improving cavity sealing in areas where light cannot reach. Examples of chemical polymerization initiators (A'-2) include organic peroxides, inorganic peroxides, transition metal complexes, etc. Organic peroxides are not particularly limited and known ones can be used. Examples of typical organic peroxides include ketone peroxides, hydroperoxides, diacyl peroxides, dialkyl peroxides, peroxyketals, peroxyesters, and peroxydicarbonates. Specific examples of these organic peroxides are those described in International Publication No. 2008 / 087977. Examples of inorganic peroxides include lithium peroxide, potassium peroxide, magnesium peroxide, calcium peroxide, barium peroxide, zinc peroxide, peroxodisulfate, and peroxodiphosphate. Examples of transition metal complexes include vanadium compounds, copper compounds, tin compounds, and cobalt compounds.

[0064] When the dental curable composition contains a chemical polymerization initiator (A'-2), the amount of chemical polymerization initiator (A'-2) is not particularly limited, but from the viewpoint of increasing the adhesive strength to dentin by promoting polymerization, it is preferably 0.001 to 10 parts by mass, more preferably 0.01 to 7 parts by mass, and even more preferably 0.1 to 5 parts by mass, based on 100 parts by mass of the total polymerizable monomer (B) contained in the dental curable composition. Depending on the embodiment, the dental curable composition may not contain a chemical polymerization initiator (A'-2).

[0065] <Polymerizable monomer (B)> The dental curable composition further comprises polymerizable monomer (B). Examples of polymerizable monomer (B) include polymerizable monomer (B-1) having an acidic group and polymerizable monomer (B-2) not having an acidic group. In one embodiment of the dental curable composition, it is preferable that polymerizable monomer (B) comprises at least one selected from the group consisting of polymerizable monomer (B-1) having an acidic group and polymerizable monomer (B-2) not having an acidic group. In one embodiment of the dental curable composition, it is preferable that polymerizable monomer (B) comprises a bifunctional monomer. Polymerizable monomer (B) may be used alone or in combination of two or more types.

[0066] (Polymerizable monomer having an acidic group (B-1)) The dental curable composition preferably contains a polymerizable monomer having an acidic group (B-1). The polymerizable monomer having an acidic group (B-1) contributes to demineralization and penetration, and as a result, the adhesive strength to dentin can be further enhanced. By including a polymerizable monomer having an acidic group (B-1), the dental curable composition of the present invention has excellent cavity sealing properties.

[0067] As the polymerizable monomer (B-1) having an acidic group, a radical polymerizable monomer is preferably used. From the viewpoint of facilitating radical polymerization, the polymerizable group of the polymerizable monomer (B-1) having an acidic group is preferably one or more selected from the group consisting of (meth)acryloyloxy group and (meth)acrylamide group. Examples of radical polymerizable monomers include (meth)acrylate monomers; (meth)acrylamide monomers; esters of organic acids such as α-cyanoacrylic acid, (meth)acrylic acid, α-halogenated acrylic acid, crotonic acid, cinnamic acid, sorbic acid, maleic acid, and itaconic acid; vinyl esters; vinyl ethers; mono-N-vinyl derivatives; styrene derivatives; and the like. Among these, (meth)acrylate monomers and (meth)acrylamide monomers are preferred from the viewpoint of curability.

[0068] Examples of polymerizable monomers having an acidic group (B-1) include monomers having at least one acidic group such as a phosphoric acid group, a pyrophosphate group, a thiophosphate group, a phosphonic acid group, a carboxylic acid group, or a sulfonic acid group.

[0069] Examples of monomers having a phosphate group include 2-(meth)acryloyloxyethyl dihydrogen phosphate, 3-(meth)acryloyloxypropyl dihydrogen phosphate, 4-(meth)acryloyloxybutyl dihydrogen phosphate, 5-(meth)acryloyloxypentyl dihydrogen phosphate, 6-(meth)acryloyloxyhexyl dihydrogen phosphate, 7-(meth)acryloyloxyheptyl dihydrogen phosphate, and 8-(meth) Cryloyloxyoctyl dihydrogen phosphate, 9-(meth)acryloyloxynonyl dihydrogen phosphate, 10-(meth)acryloyloxydecyl dihydrogen phosphate, 11-(meth)acryloyloxyundecyl dihydrogen phosphate, 12-(meth)acryloyloxidedecyl dihydrogen phosphate, 16-(meth)acryloyloxyhexadecyl dihydrogen phosphate, 20-(meth)acryloyloxyicosyl dihydrogen phosphate Hydrogen phosphate, bis[2-(meth)acryloyloxyethyl]hydrogen phosphate, bis[4-(meth)acryloyloxybutyl]hydrogen phosphate, bis[6-(meth)acryloyloxyhexyl]hydrogen phosphate, bis[8-(meth)acryloyloxyoctyl]hydrogen phosphate, bis[9-(meth)acryloyloxynonyl]hydrogen phosphate, bis[10-(meth)acryloyloxydecyl]hydrogen phosphate, 1, Examples include 3-di(meth)acryloyloxypropyl dihydrogen phosphate, 2-(meth)acryloyloxyethylphenyl hydrogen phosphate, 2-(meth)acryloyloxyethyl-(2-bromoethyl) hydrogen phosphate, 2-methacryloyloxyethyl-(4-methoxyphenyl) hydrogen phosphate, 2-methacryloyloxypropyl-(4-methoxyphenyl) hydrogen phosphate, and their acid chlorides, alkali metal salts, amine salts, etc. Among these, monomers having a divalent phosphate group with an alkylene group having 6 to 12 carbon atoms are preferred.

[0070] Examples of monomers having a pyrophosphate group include bis[2-(meth)acryloyloxyethyl] pyrophosphate, bis[4-(meth)acryloyloxybutyl] pyrophosphate, bis[6-(meth)acryloyloxyhexyl] pyrophosphate, bis[8-(meth)acryloyloxyoctyl] pyrophosphate, bis[10-(meth)acryloyloxydecyl] pyrophosphate, and their acid chlorides, alkali metal salts, amine salts, etc.

[0071] Examples of monomers having a thiophosphate group include 2-(meth)acryloyloxyethyl dihydrogen thiophosphate, 3-(meth)acryloyloxypropyl dihydrogen thiophosphate, 4-(meth)acryloyloxybutyl dihydrogen thiophosphate, 5-(meth)acryloyloxypentyl dihydrogen thiophosphate, 6-(meth)acryloyloxyhexyl dihydrogen thiophosphate, 7-(meth)acryloyloxyheptyl dihydrogen thiophosphate, and 8-(meth)acryloyloxyoctyl dihydrogen Examples include thiophosphates, 9-(meth)acryloyloxynonyldihydrogenthiophosphate, 10-(meth)acryloyloxydecyldihydrogenthiophosphate, 11-(meth)acryloyloxyundecyldihydrogenthiophosphate, 12-(meth)acryloyloxidedecyldihydrogenthiophosphate, 16-(meth)acryloyloxyhexadecyldihydrogenthiophosphate, 20-(meth)acryloyloxyicosyldihydrogenthiophosphate, and their acid chlorides, alkali metal salts, ammonium salts, etc.

[0072] Examples of monomers having a phosphonic acid group include 2-(meth)acryloyloxyethylphenylphosphonate, 5-(meth)acryloyloxypentyl-3-phosphonopropionate, 6-(meth)acryloyloxyhexyl-3-phosphonopropionate, 10-(meth)acryloyloxydecyl-3-phosphonopropionate, 6-(meth)acryloyloxyhexyl-3-phosphonoacetate, 10-(meth)acryloyloxydecyl-3-phosphonoacetate, and their acid chlorides, alkali metal salts, ammonium salts, etc.

[0073] Examples of monomers having a carboxylic acid group include monofunctional (meth)acrylic acid esters having one carboxyl group or acid anhydride group thereof in one molecule, and monofunctional (meth)acrylic acid esters having multiple carboxyl groups or acid anhydride groups thereof in one molecule.

[0074] Examples of monofunctional monomers having one carboxyl group or acid anhydride group in one molecule include (meth)acrylic acid, N-(meth)acryloylglycine, N-(meth)acryloylaspartic acid, 2-(meth)acryloyloxyethyl hydrogen succinate, 2-(meth)acryloyloxyethyl hydrogen phthalate, 2-(meth)acryloyloxyethyl hydrogen malate, O-(meth)acryloyltyrosine, N-(meth)acryloyltyrosine Examples include syn, N-(meth)acryloylphenylalanine, N-(meth)acryloyl-p-aminobenzoic acid, N-(meth)acryloyl-o-aminobenzoic acid, 2-(meth)acryloyloxybenzoic acid, 3-(meth)acryloyloxybenzoic acid, 4-(meth)acryloyloxybenzoic acid, N-(meth)acryloyl-5-aminosalicylic acid, N-(meth)acryloyl-4-aminosalicylic acid, and compounds in which the carboxyl group of these compounds has been replaced with an acid anhydride group.

[0075] Examples of monofunctional monomers having multiple carboxyl groups or acid anhydride groups within a single molecule include 6-(meth)acryloyloxyhexane-1,1-dicarboxylic acid, 9-(meth)acryloyloxynonane-1,1-dicarboxylic acid, 10-(meth)acryloyloxydecane-1,1-dicarboxylic acid, 11-(meth)acryloyloxyundecane-1,1-dicarboxylic acid, 12-(meth)acryloyloxidedodecane-1,1-dicarboxylic acid, 13-(meth)acryloyloxytridecane-1,1-dicarboxylic acid, 4-(meth)acryloyloxyethyl trimellitate, 4-(meth)acryloyloxyethyl trimellitate anhydride, and 4-(meth)acryloyloxy Examples include butyl trimellitate, 4-(meth)acryloyloxyhexyl trimellitate, 4-(meth)acryloyloxydecyl trimellitate, 2-(meth)acryloyloxyethyl-3'-(meth)acryloyloxy-2'-(3,4-dicarboxybenzoyloxy)propyl succinate, 6-(meth)acryloyloxyethylnaphthalene-1,2,6-tricarboxylic acid anhydride, 6-(meth)acryloyloxyethylnaphthalene-2,3,6-tricarboxylic acid anhydride, 4-(meth)acryloyloxyethylcarbonylpropionoyl-1,8-naphthalic acid anhydride, and 4-(meth)acryloyloxyethylnaphthalene-1,8-tricarboxylic acid anhydride.

[0076] Examples of monomers having a sulfonic acid group include 2-sulfoethyl (meth)acrylate.

[0077] Among the polymerizable monomers (B-1) having acidic groups as described above, it is preferable that they include monomers having phosphate groups or monomers having carboxylic acid groups, from the viewpoint of having good adhesive strength to dentin when used as a dental curing composition; 2-(meth)acryloyloxyethyl dihydrogen phosphate, 3-(meth)acryloyloxypropyl dihydrogen phosphate, 4-(meth)acryloyloxybutyl dihydrogen phosphate, 5-(meth)acryloyloxypentyl dihydrogen phosphate, 6-(meth ) Acryloyl oxyhexyl dihydrogen phosphate, 7-(meth)acryloyl oxyheptyl dihydrogen phosphate, 8-(meth)acryloyl oxyoctyl dihydrogen phosphate, 9-(meth)acryloyl oxynonyl dihydrogen phosphate, 10-(meth)acryloyl oxydecyl dihydrogen phosphate, 11-(meth)acryloyl oxyundecyl dihydrogen phosphate, 12-(meth)acryloyl oxide decyl dihydrogen phosphate, 16-(meth) Cryloyloxyhexadecyl dihydrogen phosphate, 20-(meth)acryloyloxyicosyl dihydrogen phosphate, 4-(meth)acryloyloxyethyl trimellitate anhydride, 4-(meth)acryloyloxyethyl trimellitate, 11-(meth)acryloyloxyundecane-1,1-dicarboxylic acid, and a mixture of 2-methacryloyloxyethyl dihydrogen phosphate and bis(2-methacryloyloxyethyl)hydrogen phosphate are more preferred; 8-(meth)acryloyloxyethyl Liloyloxyoctyl dihydrogen phosphate, 9-(meth)acryloyloxynonyl dihydrogen phosphate, 10-(meth)acryloyloxydecyl dihydrogen phosphate, 11-(meth)acryloyloxyundecyl dihydrogen phosphate, 12-(meth)acryloyloxidedecyl dihydrogen phosphate, 16-(meth)acryloyloxyhexadecyl dihydrogen phosphate, and 20-(meth)acryloyloxyicosyl dihydrogen phosphate are more preferred;From the viewpoint of balancing curability, 10-(meth)acryloyloxydecyldihydrogen phosphate is more preferable; 10-methacryloyloxydecyldihydrogen phosphate is even more preferable.

[0078] Examples of polymerizable monomers (B-1) having an acidic group, which are bifunctional monomers, include glycerol phosphate dimethacrylate.

[0079] When the dental curable composition contains a polymerizable monomer (B-1) having an acidic group, the content of the polymerizable monomer (B-1) having an acidic group is not particularly limited, but from the viewpoint of adhesive strength to dentin, it is preferably 0.5 to 40% by mass, more preferably 1 to 30% by mass, even more preferably 2 to 20% by mass, and still more preferably 2 to 15% by mass, of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition.

[0080] (Polymerizable monomer without acidic groups (B-2)) The dental curable composition preferably contains a polymerizable monomer (B-2) without acidic groups. Including a polymerizable monomer (B-2) without acidic groups promotes the penetration of the dental curable composition into the tooth structure and enables the formation of a strong resin-impregnated layer after light curing, thereby further increasing the adhesive strength to dentin. Examples of polymerizable monomers (B-2) without acidic groups include a hydrophobic monomer (B-2-1) without acidic groups (hereinafter sometimes simply referred to as "hydrophobic monomer (B-2-1)") whose solubility in water at 25°C is less than 10% by mass; and a hydrophilic monomer (B-2-2) without acidic groups (hereinafter sometimes simply referred to as "hydrophilic monomer (B-2-2)") whose solubility in water at 25°C is 10% by mass or more.

[0081] [Hydrophobic monomer (B-2-1) without acidic groups] As the hydrophobic monomer (B-2-1), a radical polymerizable monomer having polymerizable groups but without acidic groups is preferred. From the viewpoint of facilitating radical polymerization, the polymerizable group of the hydrophobic monomer (B-2-1) is preferably one or more selected from the group consisting of (meth)acryloyloxy groups and (meth)acrylamide groups.

[0082] Hydrophobic monomers (B-2-1) can be further divided into monofunctional hydrophobic monomers (B-2-1a) and polyfunctional hydrophobic monomers (B-2-1b).

[0083] - Monofunctional hydrophobic monomers (B-2-1a) Examples of monofunctional hydrophobic monomers (B-2-1a) include monofunctional monomers of aromatic compounds and monofunctional monomers of aliphatic compounds. Examples of monofunctional hydrophobic monomers (B-2-1a) include (meth)acrylate monomers and (meth)acrylamide monomers.

[0084] Examples of monofunctional hydrophobic monomers (B-2-1a) include: monofunctional (meth)acrylate monomers based on aliphatic compounds such as n-stearyl methacrylate; monofunctional (meth)acrylate monomers based on aliphatic compounds containing ether bonds such as butoxydiethylene glycol methacrylate and methoxypolyethylene glycol methacrylate (average number of moles of oxyethylene groups added: 9); monofunctional (meth)acrylate monomers based on alicyclic compounds such as cyclohexyl methacrylate, isobornyl methacrylate, and dicyclopentanyl methacrylate; 2 Examples include monofunctional (meth)acrylate monomers having aromatic ring groups such as phenoxyethyl methacrylate and phenoxybenzyl methacrylate; (meth)acrylate monomers containing heterocyclic groups (e.g., cyclic ether groups, etc.) such as tetrahydrofurfuryl methacrylate; and silane coupling agents having polymerizable groups such as γ-methacryloyloxypropyltrimethoxysilane, 8-methacryloyloxyoctyltrimethoxysilane, and 11-methacryloyloxyundecyltrimethoxysilane (hereinafter also referred to as "11-MUS"). Among monofunctional (meth)acrylate monomers having aromatic ring groups, those having one or two phenyl groups are preferred. Among (meth)acrylate monomers containing heterocyclic groups, those having one or two heterocyclic groups (e.g., cyclic ether groups, etc.) are preferred. Among these, tetrahydrofurfuryl methacrylate (hereinafter also referred to as "THF-MA"), benzyl methacrylate (hereinafter also referred to as "BEMA"), phenoxybenzyl methacrylate (hereinafter also referred to as "POB-MA"), and 2-phenoxyethyl methacrylate (hereinafter also referred to as "PEMA") are preferred from the viewpoint of mechanical strength and the effect of reducing polymerization shrinkage stress.

[0085] • Polyfunctional hydrophobic monomers (B-2-1b) Examples of polyfunctional hydrophobic monomers (B-2-1b) include difunctional hydrophobic monomers of aromatic compounds, difunctional hydrophobic monomers of aliphatic compounds, and hydrophobic monomers with three or more functions.

[0086] Examples of bifunctional hydrophobic monomers of aromatic compounds include 2,2-bis((meth)acryloyloxyphenyl)propane, 2,2-bis[4-(3-(meth)acryloyloxy-2-hydroxypropoxy)phenyl]propane, 2,2-bis(4-(meth)acryloyloxyethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxypolyethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxydiethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxytriethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxytetraethoxyphenyl)propane, and 2,2-bis(4-(meth)acryloyloxypentaethoxyphenyl) Examples include 2,2-(4-(meth)acryloyloxydipropoxyphenyl)propane, 2-(4-(meth)acryloyloxydiethoxyphenyl)-2-(4-(meth)acryloyloxyethoxyphenyl)propane, 2-(4-(meth)acryloyloxydiethoxyphenyl)-2-(4-(meth)acryloyloxytriethoxyphenyl)propane, 2-(4-(meth)acryloyloxydipropoxyphenyl)-2-(4-(meth)acryloyloxytriethoxyphenyl)propane, 2,2-(4-(meth)acryloyloxypropoxyphenyl)propane, and 2,2-(4-(meth)acryloyloxyisopropoxyphenyl)propane. Among these, from the viewpoint of mechanical strength, refractive index adjustment, and handling, 2,2-bis[4-(3-methacryloyloxy-2-hydroxypropoxy)phenyl]propane (hereinafter also referred to as "Bis-GMA"), 2,2-bis(4-(meth)acryloyloxyethoxyphenyl)propane, and 2,2-bis(4-methacryloyloxypolyethoxyphenyl)propane (average number of moles of ethoxy groups added: 2.6, hereinafter also referred to as "D-2.6E").), 2,2-bis(4-(meth)acryloyloxydiethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxytriethoxyphenyl)propane, 2,2-bis(4-(meth)acryloyloxytetraethoxyphenyl)propane, and 2,2-bis(4-(meth)acryloyloxypentaethoxyphenyl)propane are preferred.

[0087] Examples of aliphatic compound-based difunctional hydrophobic monomers include glycerol di(meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, butylene glycol di(meth)acrylate, neopentyl glycol di(meth)acrylate, 1,3-butanediol di(meth)acrylate, 1,5-pentanediol di(meth)acrylate, 1,6-hexanediol di(meth)acrylate, and 1,10-decanediol. Examples include di(meth)acrylate, 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl)di(meth)acrylate, N-methacryloyloxyethyl acrylamide (hereinafter also referred to as "MAEA"), N-methacryloyloxypropyl acrylamide, N-methacryloyloxybutyl acrylamide, N-(1-ethyl-(2-methacryloyloxy)ethyl) acrylamide, and N-(2-(2-methacryloyloxyethoxy)ethyl) acrylamide. Among these, triethylene glycol diacrylate, triethylene glycol dimethacrylate (hereinafter also referred to as "3G"), neopentyl glycol di(meth)acrylate, 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, 2,2,4-trimethylhexamethylenebis(2-carbamoyloxyethyl) dimethacrylate (hereinafter also referred to as "UDMA"), and 1,10-decanediol dimethacrylate (hereinafter also referred to as "DD") are preferred from the viewpoint of mechanical strength. From the viewpoint of polymerization shrinkage stress, 1,2-bis(3-methacryloyloxy-2-hydroxypropoxy)ethane, UDMA, and DD are preferred. From the viewpoint of adhesive strength to tooth structure, especially dentin, MAEA and N-methacryloyloxypropyl acrylamide are preferred.

[0088] Examples of hydrophobic monomers with three or more functionalities include trimethylolpropane tri(meth)acrylate, trimethylolethane tri(meth)acrylate, trimethylolmethane tri(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, N,N-(2,2,4-trimethylhexamethylene)bis[2-(aminocarboxy)propane-1,3-diol]tetra(meth)acrylate, and 1,7-diacryloxy-2,2,6,6-tetra(meth)acryloyloxymethyl-4-oxaheptane. Among these, N,N-(2,2,4-trimethylhexamethylene)bis[2-(aminocarboxy)propane-1,3-diol]tetramethacrylate is preferred from the viewpoint of mechanical strength.

[0089] Among the hydrophobic monomers (B-2-1) mentioned above, from the viewpoint of mechanical strength, difunctional hydrophobic monomers of aromatic compounds, difunctional hydrophobic monomers of aliphatic compounds, and monofunctional hydrophobic monomers are preferred. As difunctional monomers of aromatic compounds, Bis-GMA and D-2.6E are preferred. As difunctional monomers of aliphatic compounds, 3G, neopentyl glycol di(meth)acrylate, UDMA, DD, and MAEA are preferred. As monofunctional hydrophobic monomers, THF-MA, BEMA, POB-MA, and PEMA are preferred.

[0090] Among the hydrophobic monomers (B-2-1) mentioned above, from the viewpoint of mechanical strength, hydrophobic monomers without hydroxyl groups (monofunctional hydrophobic monomers without hydroxyl groups, difunctional hydrophobic monomers of aromatic compound type without hydroxyl groups, and difunctional hydrophobic monomers of aliphatic compound type without hydroxyl groups) are preferred, D-2.6E, DD, UDMA, MAEA, THF-MA, BEMA, POB-MA, and PEMA are more preferred, and D-2.6E, DD, MAEA, and THF-MA are even more preferred.

[0091] When the dental curable composition contains a hydrophobic monomer (B-2-1), the content of the hydrophobic monomer (B-2-1) is not particularly limited, but it is preferably 4 to 98% by mass, more preferably 8 to 95% by mass, and even more preferably 15 to 92% by mass, of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition of the present invention. When the content of the hydrophobic monomer (B-2-1) is below the upper limit, the wettability of the dental curable composition to dentin tends to be good, and when it is above the lower limit, the mechanical strength of the desired cured product tends to be obtained.

[0092] [Hydrophilic monomer (B-2-2) without acidic groups] Hydrophilic monomer (B-2-2) can improve the wettability and penetration of dental curable compositions into dentin, thereby improving the adhesive strength to dentin. As the hydrophilic monomer (B-2-2), a radical polymerizable monomer having polymerizable groups but without acidic groups is preferred. From the viewpoint of facilitating radical polymerization, the polymerizable group of the hydrophilic monomer (B-2-2) is preferably one or more selected from the group consisting of (meth)acryloyloxy groups and (meth)acrylamide groups.

[0093] The hydrophilic monomer (B-2-2) has a solubility of 10% by mass or more in water at 25°C, preferably 30% by mass or more, and more preferably soluble in water at any ratio at 25°C. Examples of hydrophilic monomers (B-2-2) that have hydrophilic groups such as hydroxyl groups, oxymethylene groups, oxyethylene groups, oxypropylene groups, and amide groups are preferred.

[0094] Examples of hydrophilic monomers (B-2-2) include hydrophilic monofunctional (meth)acrylate monomers such as 2-hydroxyethyl (meth)acrylate, 3-hydroxypropyl (meth)acrylate, 2-hydroxypropyl (meth)acrylate, 1,3-dihydroxypropyl (meth)acrylate, 2,3-dihydroxypropyl (meth)acrylate, 2-((meth)acryloyloxy)ethyltrimethylammonium chloride, polyethylene glycol di(meth)acrylate (average number of moles of oxyethylene groups added: 9 or more); Examples include hydrophilic monofunctional (meth)acrylamide monomers such as N-methylol(meth)acrylamide, N-hydroxyethyl(meth)acrylamide, N,N-bis(2-hydroxyethyl)(meth)acrylamide, N-methoxymethyl(meth)acrylamide, N-ethoxymethyl(meth)acrylamide, diacetone(meth)acrylamide, 4-(meth)acryloylmorpholine, N-trihydroxymethyl-N-methyl(meth)acrylamide, N,N-dimethylacrylamide, and N,N-diethylacrylamide. Among these hydrophilic monomers (B-2-2), 2-hydroxyethyl(meth)acrylate, 2,3-dihydroxypropyl(meth)acrylate, and hydrophilic monofunctional (meth)acrylamide monomers are preferred from the viewpoint of adhesive strength to dentin, and 2-hydroxyethyl(meth)acrylate, N,N-dimethylacrylamide, and N,N-diethylacrylamide are more preferred.

[0095] The content of the hydrophilic monomer (B-2-2) in the dental curable composition is not particularly limited, but is preferably 0.1 to 94% by mass, more preferably 0.5 to 50% by mass, and even more preferably 1 to 35% by mass, of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition. When the content of the hydrophilic monomer (B-2-2) is above the lower limit, it is easier to obtain a sufficient improvement in adhesive strength to dentin, and when it is below the upper limit, it is easier to obtain the desired mechanical strength of the cured product. Depending on the embodiment, the dental curable composition may not contain the hydrophilic monomer (B-2-2).

[0096] When the dental curable composition contains a polymerizable monomer (B-2) that does not have an acidic group, the total content of the polymerizable monomer (B-2) that does not have an acidic group is preferably 5 to 98% by mass, more preferably 10 to 95% by mass, and even more preferably 20 to 90% by mass, of the total 100% by mass of polymerizable monomer (B) contained in the dental curable composition of the present invention, from the viewpoint of the properties of the dental curable composition.

[0097] In the aforementioned dental curable composition, the mass ratio of hydrophobic monomer (B-2-1) to hydrophilic monomer (B-2-2) [hydrophobic monomer (B-2-1): hydrophilic monomer (B-2-2)] is preferably 1:0 to 1:2, more preferably 1:0 to 1:1, and even more preferably 1:0 to 1:0.7, from the viewpoint of improving adhesive strength to dentin and reducing water absorption and solubility of the cured product.

[0098] (Difunctional Monomer) The dental curing composition preferably contains a difunctional monomer from the viewpoint of improving the adhesive strength to dentin. By including a difunctional monomer, a strong resin-impregnated layer can be formed, thereby further increasing the adhesive strength to dentin. The difunctional monomer may be a polymerizable monomer (B-1) having an acidic group that is difunctional, or a polymerizable monomer (B-2) that does not have an acidic group that is difunctional, or both may be difunctional. Examples of difunctional monomers include the aromatic compound-based difunctional hydrophobic monomer and the aliphatic compound-based difunctional hydrophobic monomer, and the same applies to preferred difunctional monomers. When the dental curable composition contains a difunctional monomer, the content of the difunctional monomer is not particularly limited, but it is preferably 5 to 98% by mass, more preferably 15 to 95% by mass, and even more preferably 20 to 92% by mass, of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition. When the content of the difunctional monomer is above the lower limit, the desired mechanical strength of the cured product is more easily obtained, and when it is below the upper limit, the wettability of the dental curable composition to dentin is more easily improved.

[0099] When the dental curable composition contains polymerizable monomer (B), the total content of polymerizable monomer (B) is not particularly limited, but from the viewpoint of improving the adhesive strength to dentin, it is preferably 6 to 99% by mass, more preferably 12 to 80% by mass, and even more preferably 25 to 70% by mass, of 100% by mass of the total dental curable composition. In one embodiment of the present invention, from the viewpoint of improving the adhesive strength to dentin, the total content of polymerizable monomer (B) is preferably 15 to 99% by mass, more preferably 30 to 80% by mass, and even more preferably 50 to 70% by mass, of 100% by mass of the total dental curable composition. In one embodiment of the present invention, from the viewpoint of improving the adhesive strength to dentin, the total content of polymerizable monomer (B) is preferably 6 to 70% by mass, more preferably 12 to 60% by mass, and even more preferably 25 to 45% by mass, of 100% by mass of the total dental curable composition.

[0100] <Organic amine compound (C)> The dental curable composition preferably further contains an organic amine compound (C) from the viewpoint of improving the mechanical strength of the cured product. Organic amine compound (C) may be used alone or in combination of two or more types.

[0101] Examples of organic amine compounds (C) include aliphatic amine compounds and aromatic amine compounds.

[0102] Examples of aliphatic amines include primary aliphatic amines such as n-butylamine, n-hexylamine, and n-octylamine; secondary aliphatic amines such as diisopropylamine, dibutylamine, and N-methylethanolamine; and tertiary aliphatic amines such as N-methyldiethanolamine, N-ethyldiethanolamine, N-n-butyldiethanolamine, N-lauryldiethanolamine, 2-(dimethylamino)ethyl methacrylate, N-methyldiethanolamine dimethacrylate, N-ethyldiethanolamine dimethacrylate, triethanolamine monomethacrylate, triethanolamine dimethacrylate, triethanolamine trimethacrylate, triethanolamine, trimethylamine, triethylamine, and tributylamine. Among these, tertiary aliphatic amines are preferred from the viewpoint of curability and storage stability, and N-methyldiethanolamine and triethanolamine are more preferred.

[0103] The aromatic amine may be any of the primary aromatic amine, secondary aromatic amine, or tertiary aromatic amine, but a tertiary aromatic amine is preferred. Examples of aromatic amine compounds include N,N-bis(2-hydroxyethyl)-3,5-dimethylaniline, N,N-bis(2-hydroxyethyl)-p-toluidine, N,N-bis(2-hydroxyethyl)-3,4-dimethylaniline, N,N-bis(2-hydroxyethyl)-4-ethylaniline, N,N-bis(2-hydroxyethyl)-4-isopropylaniline, N,N-bis(2-hydroxyethyl)-4-tert-butylaniline, N,N-bis(2-hydroxyethyl)-3,5-diisopropylaniline, N,N-bis(2-hydroxyethyl)-3,5-di-tert-butylaniline, N,N-dimethylaniline, N,N-dimethyl-p-toluidine, N,N-dimethyl-m-toluidine, N,N-diethyl- Examples include p-toluidine, N,N-dimethyl-3,5-dimethylaniline, N,N-dimethyl-3,4-dimethylaniline, N,N-dimethyl-4-ethylaniline, N,N-dimethyl-4-isopropylaniline, N,N-dimethyl-4-tert-butylaniline, N,N-dimethyl-3,5-di-tert-butylaniline, ethyl 4-(N,N-dimethylamino)benzoate, methyl 4-(N,N-dimethylamino)benzoate, propyl 4-(N,N-dimethylamino)benzoate, n-butoxyethyl 4-(N,N-dimethylamino)benzoate, 2-(methacryloyloxy)ethyl 4-(N,N-dimethylamino)benzoate, benzophenone, and butyl 4-(N,N-dimethylamino)benzoate. Among these, from the viewpoint of curability, at least one selected from the group consisting of N,N-bis(2-hydroxyethyl)-p-toluidine, 4-(N,N-dimethylamino)ethyl benzoate, 4-(N,N-dimethylamino)n-butoxyethyl benzoate, and 4-(N,N-dimethylamino)benzophenone is preferred.

[0104] In one embodiment of the present invention, when the dental curable composition contains an organic amine compound (C), the content of the organic amine compound (C) is not particularly limited, but is preferably 0.001 to 20% by mass, more preferably 0.01 to 10% by mass, even more preferably 0.03 to 8% by mass, and still more preferably 0.05 to 5% by mass, based on 100% by mass of the total dental curable composition. In one embodiment of the present invention, when the dental curable composition contains an organic amine compound (C), the content of the organic amine compound (C) is not particularly limited, but is preferably 0.001 to 20 parts by mass, more preferably 0.01 to 10 parts by mass, even more preferably 0.03 to 8 parts by mass, and still more preferably 0.05 to 5 parts by mass, based on 100 parts by mass of the total polymerizable monomer (B) contained in the dental curable composition. When the content of the organic amine compound (C) is above the lower limit, polymerization proceeds sufficiently, and a sufficient improvement in adhesive strength to dentin is easily obtained. When it is below the upper limit, sufficient adhesive strength to dentin is easily obtained, and furthermore, the precipitation of the organic amine compound (C) itself from the dental curable composition can be suppressed. In one embodiment of the present invention, from the same viewpoint as above, the content of the organic amine compound (C) is preferably 0.1 to 20 parts by mass, more preferably 0.5 to 15 parts by mass, even more preferably 1 to 10 parts by mass, and even more preferably 2 to 7 parts by mass, based on 100 parts by mass of the total polymerizable monomer (B) contained in the dental curable composition of the present invention. In another embodiment of the present invention, the content of the organic amine compound (C) is preferably 0.001 to 5 parts by mass, more preferably 0.01 to 3 parts by mass, even more preferably 0.03 to 1 part by mass, and still more preferably 0.05 to 0.5 parts by mass, based on 100 parts by mass of the total polymerizable monomer (B) contained in the dental curable composition of the present invention, from the same viewpoint as described above.

[0105] <Polymerization accelerators (D) other than organic amine compounds (C)> The dental curable composition may contain polymerization accelerators (D) other than organic amine compounds (C) (hereinafter sometimes simply referred to as "polymerization accelerators (D)"). Examples of polymerization accelerators (D) include sulfinic acid and its salts, borate compounds, barbituric acid derivatives, triazine compounds, copper compounds, tin compounds, vanadium compounds, halogen compounds, aldehydes, thiol compounds, sulfites, bisulfites, thiourea compounds, benzotriazole compounds, etc. Among these, sulfinic acid and its salts, sulfites, and benzotriazole compounds are preferred. Polymerization accelerators (D) may be used alone or in combination of two or more.

[0106] Examples of sulfinic acids include p-toluenesulfinic acid, m-toluenesulfinic acid, o-toluenesulfinic acid, benzenesulfinic acid, ethylbenzenesulfinic acid, decylbenzenesulfinic acid, dodecylbenzenesulfinic acid, 2,4,6-trimethylbenzenesulfinic acid, 2,4,6-triethylbenzenesulfinic acid, 2,4,6-triisopropylbenzenesulfinic acid, chlorobenzenesulfinic acid, naphthalenesulfinic acid, and the like. Examples of sulfinic acid salts include lithium salts, sodium salts, potassium salts, rubidium salts, cesium salts, magnesium salts, calcium salts, strontium salts, iron salts, zinc salts, ammonium salts, tetramethylammonium salts, and tetraethylammonium salts of the above sulfinic acids. Among these, from the viewpoint of curability and storage stability of dental curable compositions, lithium salts, sodium salts, potassium salts, magnesium salts, or calcium salts of sulfinic acid selected from the group consisting of 2,4,6-trimethylbenzenesulfinic acid and 2,4,6-triisopropylbenzenesulfinic acid are preferred, and lithium salts, sodium salts, potassium salts, magnesium salts, or calcium salts of 2,4,6-triisopropylbenzenesulfinic acid are more preferred.

[0107] Examples of sulfites include sodium sulfite, potassium sulfite, calcium sulfite, ammonium sulfite, sodium bisulfite, and potassium bisulfite. Among these, sodium sulfite is preferred.

[0108] When the dental curable composition contains a polymerization accelerator (D), the content of the polymerization accelerator (D) is not particularly limited, but from the viewpoint of the curability of the dental curable composition, it is preferably 0.001 to 20 parts by mass, more preferably 0.01 to 10 parts by mass, even more preferably 0.03 to 8 parts by mass, and even more preferably 0.05 to 5 parts by mass, based on 100 parts by mass of the total polymerizable monomers (B) contained in the dental curable composition of the present invention. When the content of the polymerization accelerator (D) is above the lower limit, polymerization proceeds sufficiently and it is easy to obtain a sufficient improvement in adhesion strength to dentin, and when it is below the upper limit, it is easy to obtain sufficient adhesion strength to dentin and furthermore, the precipitation of the polymerization accelerator (D) itself from the dental curable composition can be suppressed. Depending on the embodiment, the dental curable composition may not contain the polymerization accelerator (D).

[0109] <Filler (E)> The dental hardening composition may further contain a filler (E) from the viewpoint of increasing the mechanical strength of the hardened product, such as the flexural strength. Examples of filler (E) include inorganic fillers, organic-inorganic composite fillers, and organic fillers. Filler (E) may be used alone or in combination of two or more types.

[0110] The inorganic filler material is not particularly limited and includes glass, ceramics, and composite oxides. Glass is preferably that which contains 5% or more silica by mass, more preferably 10% or more silica by mass, and may optionally contain oxides of heavy metals, boron, aluminum, etc. Examples of inorganic fillers include fused silica, quartz, soda-lime silica glass, E glass, C glass, borosilicate glass (Pyrex® glass), barium glass, strontium borosilicate glass, lanthanum glass ceramics, fluoroaluminosilicate glass, alumina, silica-titania, silica-zirconia, ytterbium oxide, silica-coated ytterbium fluoride, aluminosilicate glass, barium boroaluminosilicate glass, calcium fluoroaluminosilicate glass, strontium fluoroaluminosilicate glass, barium fluoroaluminosilicate glass, strontium calcium fluoroaluminosilicate glass, diatomaceous earth, kaolin, clay minerals (montmorillonite, etc.), activated clay, synthetic zeolite, mica, calcium fluoride, ytterbium fluoride, yttrium fluoride, calcium phosphate, barium sulfate, zirconium oxide, titanium dioxide, and hydroxyapatite. Among these, inorganic fillers containing metallic elements such as aluminum, strontium, zirconium, barium, lanthanum, ytterbium, titanium, and bismuth as constituent elements, which have high X-ray contrast properties, are preferred. Specifically, for example, barium glass, alumina, silica-titania, silica-zirconia, and silica-coated ytterbium fluoride are preferred. Inorganic fillers can be used as inorganic fillers with a relatively high refractive index. Among these, from the viewpoint of excellent mechanical strength and transparency of the resulting dental curable composition, quartz, silica, silica-titania, silica-zirconia, barium glass, ytterbium oxide, and silica-coated ytterbium fluoride are preferred, and quartz, silica, silica-titania, silica-zirconia, barium glass, and silica-coated ytterbium fluoride are more preferred. From the viewpoint of radiopaqueness of the dental curable composition, silica-zirconia, barium glass, and silica-coated ytterbium fluoride are preferred.

[0111] The average particle size of the inorganic filler is preferably 0.001 to 50 μm, more preferably 0.003 to 20 μm, and even more preferably 0.005 to 10 μm, from the viewpoint of improving the handling properties and mechanical strength of the dental curable composition. In this invention, if the inorganic filler is surface-treated as described below, the average particle size of the inorganic filler refers to the average particle size before surface treatment.

[0112] The dental curing composition containing an inorganic filler as filler (E) is suitable, for example, for dental self-adhesive composite resins.

[0113] Inorganic fillers may be commercially available. Examples of commercially available products include silica such as Aerosil® 90, Aerosil® 130, Aerosil® 150, Aerosil® 200, Aerosil® 255, Aerosil® 300, Aerosil® 380, Aerosil® OX50, Aerosil® R972 (all manufactured by Nippon Aerosil Co., Ltd.), GM27884, 8 Examples include barium glass such as 235 (manufactured by Schott), product code "E-3000" (manufactured by Esstec), strontium borosilicate glass (E-4000, manufactured by Esstec), lanthanum glass ceramics (GM31684, manufactured by Schott), and fluoroaluminosilicate glass (GM35429, G018-091, G018-117, manufactured by Schott).

[0114] The inorganic filler may be amorphous, crystalline, or a mixture of both, but it is preferable that it contains at least an amorphous portion.

[0115] The shape of the inorganic filler is not particularly limited, and examples include amorphous fillers (crushed fillers) and spherical fillers. Among these, amorphous fillers are preferred from the viewpoint of improving the mechanical strength of the hardened product of the dental hardening composition, and spherical fillers are preferred from the viewpoint of handling. A "spherical filler" is a filler in which, in its projected image, the particles are rounded, and when the maximum length of the particle is defined as the major axis and the maximum length in the direction perpendicular to the major axis is defined as the minor axis, the average ratio [minor axis / major axis] of 200 or more arbitrarily selected particles is 0.6 to 1.0.

[0116] In order to adjust the mechanical strength, fluidity, etc., of the inorganic filler in the dental curable composition, it is preferable to pre-treat the surface with a known surface treatment agent such as a silane coupling agent. For example, by surface-treating the hydroxyl groups present on the surface of the inorganic filler with a surface treatment agent, an inorganic filler with surface-treated hydroxyl groups can be obtained.

[0117] Examples of surface treatment agents include vinyltrimethoxysilane, vinyltriethoxysilane, vinyltrichlorosilane, vinyltri(β-methoxyethoxy)silane, γ-methacryloyloxypropyltrimethoxysilane, 8-methacryloyloxyoctyltrimethoxysilane, 11-methacryloyloxyundecyltrimethoxysilane, γ-glycidoxypropyltrimethoxysilane, γ-mercaptopropyltrimethoxysilane, and γ-aminopropyltriethoxysilane. Among these, vinyltrimethoxysilane, γ-methacryloyloxypropyltrimethoxysilane, 8-methacryloyloxyoctyltrimethoxysilane, 11-methacryloyloxyundecyltrimethoxysilane, and γ-aminopropyltriethoxysilane are preferred.

[0118] The surface treatment method can be any known method without particular limitation. For example, it can be a method of spraying the surface treatment agent while vigorously stirring the inorganic filler, a method of dispersing or dissolving the inorganic filler and the surface treatment agent in a suitable solvent and then removing the solvent, or a method of hydrolyzing the alkoxy groups of the surface treatment agent with an acid catalyst in an aqueous solution to convert them to silanol groups, attaching them to the inorganic filler surface in the aqueous solution, and then removing the water. In any of these methods, the reaction between the inorganic filler surface and the surface treatment agent can be completed and the surface treatment performed by heating in the range of 50 to 150°C, for example. The amount of surface treatment is not particularly limited. For example, 0.1 to 40 parts by mass of the surface treatment agent can be used per 100 parts by mass of the inorganic filler before treatment.

[0119] Organic-inorganic composite fillers are obtained by pre-adding polymerizable monomers to the aforementioned inorganic filler, forming a paste, polymerizing the polymerizable monomers, and then pulverizing the paste. In other words, an organic-inorganic composite filler is a filler containing a polymer of an inorganic filler and a polymerizable monomer. Examples of polymerizable monomers used in organic-inorganic composite fillers include the same polymerizable monomer (B) mentioned above, and as organic-inorganic composite fillers, for example, a mixture of Bis-GMA, 3G, and a surface-treated silica filler, polymerized and then pulverized can be used. The shape of the organic-inorganic composite filler is not particularly limited; for example, it may be an amorphous filler or a spherical filler. From the viewpoint of improving mechanical strength, it is preferable for organic-inorganic composite fillers to be surface-treated. Examples and preferred types of surface treatment agents are the same as those mentioned above for surface treatment agents for inorganic fillers.

[0120] Examples of organic filler materials include polymethyl methacrylate, polyethyl methacrylate, methyl methacrylate-ethyl methacrylate copolymer, crosslinked polymethyl methacrylate, crosslinked polyethyl methacrylate, polyamide, polyvinyl chloride, polystyrene, chloroprene rubber, nitrile rubber, ethylene-vinyl acetate copolymer, styrene-butadiene copolymer, acrylonitrile-styrene copolymer, and acrylonitrile-styrene-butadiene copolymer. The shape of the organic filler is not particularly limited; for example, it may be an amorphous filler or a spherical filler.

[0121] In this specification, the average particle diameter of filler (E) can be determined by laser diffraction scattering or electron microscopy observation of the particles. Specifically, laser diffraction scattering is suitable for measuring particle diameters of 0.1 μm or larger, while electron microscopy observation is suitable for measuring particle diameters of ultrafine particles smaller than 0.1 μm. 0.1 μm is a measurement value obtained by laser diffraction scattering. That is, laser diffraction scattering is used to determine whether or not the particle diameter is 0.1 μm or larger. In the case of particles composed of aggregated primary particles, such as agglomerated particles, there are average particle diameters for the primary particles and average particle diameters for the secondary particles, but the average particle diameter of filler (E) is defined as the average primary particle diameter, which is the average particle diameter of the primary particles.

[0122] Laser diffraction scattering can be used, for example, with a laser diffraction particle size distribution analyzer (SALD-2300: manufactured by Shimadzu Corporation), to measure the volume-based median diameter (D50) using a 0.2% sodium hexametaphosphate aqueous solution as the dispersion medium.

[0123] Electron microscopy observation can be performed, for example, by taking an electron microscope (Hitachi, Ltd., S-4000 model) photograph of a particle, and measuring the particle diameter of 200 or more particles observed within the unit field of view of the photograph using image analysis particle size distribution measurement software (Mac-View (Mountec Co., Ltd.)). In this case, the particle diameter per particle is determined as the average value of the maximum length (major axis) of the particle and the maximum length (minor axis) in the direction perpendicular to the maximum length. The average particle diameter is then calculated by taking the arithmetic mean of the particle diameters of the 200 or more particles whose particle diameters have been determined.

[0124] When the dental curable composition contains filler (E), the content of filler (E) is not particularly limited, but from the viewpoint of handling properties and mechanical strength of the cured product, it is preferably 1 to 90% by mass, more preferably 2 to 85% by mass, and even more preferably 3 to 80% by mass, of 100% by mass of the total dental curable composition. In one embodiment of the present invention, the content of filler (E) is preferably 1 to 20% by mass, more preferably 2 to 10% by mass, and even more preferably 3 to 5% by mass, of 100% by mass of the total dental curable composition. In another embodiment of the present invention, the content of filler (E) is preferably 40 to 90% by mass, more preferably 50 to 85% by mass, and even more preferably 60 to 80% by mass, of 100% by mass of the total dental curable composition.

[0125] <Solvent> The dental curing composition may further contain a solvent. Examples of solvents include water, organic solvents, and mixed solvents thereof. One solvent may be used alone, or two or more solvents may be used in combination.

[0126] The water used is preferably purified water such as distilled water or deionized water, as it contains fewer impurities that could negatively affect adhesion. When the dental curable composition contains water, the amount of water is not particularly limited, but it is preferably 1 to 50 parts by mass, more preferably 5 to 30 parts by mass, and even more preferably 10 to 25 parts by mass, based on 100 parts by mass of the total polymerizable monomer (B) contained in the dental curable composition. When the water content is within the above range, a sufficient demineralization-promoting effect is easily obtained. Depending on the embodiment, the dental curable composition may not contain water.

[0127] When the dental curable composition contains an organic solvent, its adhesiveness, applicability, and penetration into dentin can be further improved, and the separation of each component of the dental curable composition can be further prevented. As for the organic solvent, for example, one that has a boiling point of 150°C or less under normal pressure and a solubility in water at 25°C of 5% by mass or more, more preferably 30% by mass or more, and even more preferably one that is soluble in water in any proportion.

[0128] Examples of organic solvents include methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-methyl-2-propanol, acetone, methyl ethyl ketone, tetrahydrofuran, diethyl ether, diisopropyl ether, hexane, toluene, chloroform, ethyl acetate, and butyl acetate. Among these, water-soluble organic solvents are preferred from the viewpoint of improving safety for living organisms and ease of removal due to volatility. Specifically, ethanol, 2-propanol, 2-methyl-2-propanol, acetone, and tetrahydrofuran are preferred, and ethanol, 2-propanol, 2-methyl-2-propanol, and tetrahydrofuran are more preferred. When the dental curable composition contains an organic solvent, the content of the organic solvent is not particularly limited, but is preferably 1 to 70 parts by mass, more preferably 5 to 50 parts by mass, and even more preferably 10 to 30 parts by mass, based on 100 parts by mass of the total polymerizable monomer (B) contained in the dental curable composition. The dental curable composition of the present invention may not contain an organic solvent depending on its embodiment.

[0129] <Additives> The dental curable composition of the present invention may further contain known additives, to the extent that they do not contradict the purpose of the present invention. Examples of such additives include polymerization inhibitors, fluoride ion-releasing substances, ultraviolet absorbers, fluorescent agents, colorants (pigments, dyes), antioxidants, thickeners, and silane coupling agents. Additives may be used individually or in combination of two or more. Depending on the embodiment, the dental curable composition may not contain any of the additives listed above.

[0130] (Polymerization Inhibitor) The dental curable composition preferably contains a polymerization inhibitor from the viewpoint of adjusting storage stability and curability. Examples of polymerization inhibitors include hydroquinone, hydroquinone monomethyl ether, dibutylhydroquinone, dibutylhydroquinone monomethyl ether, tert-butylcatechol, 2-tert-butyl-4,6-dimethylphenol, 2,6-di-tert-butylphenol, and 3,5-di-tert-butyl-4-hydroxytoluene. A single polymerization inhibitor may be used, or two or more may be used in combination. When the dental curable composition contains a polymerization inhibitor, the amount of polymerization inhibitor is not particularly limited, but it is preferably 0.001 to 1.0 parts by mass per 100 parts by mass of the total polymerizable monomer (B) contained in the dental curable composition.

[0131] (Fluoride-releasing substances) The dental curing composition may further contain a fluoride-releasing substance. By containing a fluoride-releasing substance, the dental curing composition can impart acid resistance to tooth structure. Examples of fluoride-releasing substances include fluoride-releasing polymers such as copolymers of methyl methacrylate and methacrylate fluoride; and metal fluorides such as sodium fluoride, potassium fluoride, sodium monofluorophosphate, lithium fluoride, and ytterbium fluoride. One type of fluoride-releasing substance may be used alone, or two or more types may be used in combination.

[0132] (Ultraviolet Absorber) The dental curing composition may contain an ultraviolet absorber from the viewpoint of photostability to ambient light such as fluorescent lamps and LEDs, and from the viewpoint of suppressing discoloration of the cured product. Examples of ultraviolet absorbers include benzotriazole compounds such as 2-(2-hydroxyphenyl)benzotriazole, 2-(2-hydroxy-5-methylphenyl)benzotriazole, 2-(2-hydroxy-5-ethylphenyl)benzotriazole, 2-(2-hydroxy-5-propylphenyl)benzotriazole, 2-(2-hydroxy-5-tert-octylphenyl)benzotriazole, and 2-(3-tert-butyl-2-hydroxy-5-methylphenyl)-5-chloro-2H-benzotriazole (Tinuvin 326); benzimidazole compounds; etc. Among these, Tinuvin 326 is preferred. These ultraviolet absorbers may be used individually or in combination of two or more.

[0133] (Fluorescent agent) The dental curing composition may contain a fluorescent agent from an aesthetic standpoint to reproduce a color tone close to that of tooth structure. Any known fluorescent agent can be used without any limitations, but phthalate ester fluorescent agents are preferred. Examples of phthalate ester fluorescent agents include dimethyl 2,5-dihydroxyterephthalate, diethyl 2,5-dihydroxyterephthalate, dimethylaminoterephthalate, and diethylaminoterephthalate. Among these, phthalate ester fluorescent agents substituted with hydroxyl groups, such as diethyl 2,5-dihydroxyterephthalate, are preferred. One fluorescent agent may be used alone, or two or more may be used in combination.

[0134] (Coloring agent) The dental curing composition may contain a coloring agent in order to reproduce a color similar to that of tooth structure. The type of coloring agent is not particularly limited, and can be appropriately selected from, for example, inorganic pigments, organic pigments, etc., depending on the desired color of the dental curing composition. One type of coloring agent may be used alone, or two or more types may be used in combination.

[0135] Examples of inorganic pigments include chromates such as lead yellow, zinc yellow, and barium yellow; ferrocyanides such as Prussian blue; sulfides such as vermilion, cadmium yellow, zinc sulfide, and cadmium red; sulfates such as barium sulfate, zinc sulfate, and strontium sulfate; oxides such as zinc oxide, antimony white, titanium white, red iron oxide, iron black, and chromium oxide; hydroxides such as aluminum hydroxide; silicates such as calcium silicate and ultramarine; and carbons such as carbon black and graphite.

[0136] Examples of organic pigments include nitroso pigments such as naphthol green B and naphthol green Y; nitro pigments such as naphthol yellow S and lysol fast yellow 2G; insoluble azo pigments such as permanent red 4R, brilliant fast scarlet, Hansa yellow, and benzidine yellow; poorly soluble azo pigments such as lysol red, lake red C, and lake red D; soluble azo pigments such as brilliant carmine 6B, permanent red F5R, pigment scarlet 3B, and Bordeaux 10B; phthalocyanine pigments such as phthalocyanine blue, phthalocyanine green, and sky blue; basic dye pigments such as rhodamine lake, malachite green lake, and methyl violet lake; and acid dye pigments such as peacock blue lake, eosin lake, quinoline yellow lake, and aluminum lake.

[0137] Among these colorants, inorganic pigments such as titanium white, red iron oxide, iron black, and yellow iron oxide are preferred because they have superior heat resistance, light resistance, or both compared to organic pigments.

[0138] (Silane coupling agent) As the silane coupling agent, the silane coupling agent exemplified as a surface treatment agent for filler (E) can be used.

[0139] <Uses of Dental Curing Composition> Because the dental curing composition has high adhesive strength to dentin, it can be suitably applied to dental bonding materials, dental filling composite resins, or dental cements. When the dental curing composition is a dental filling composite resin, the dental filling composite resin is also suitable as a dental self-adhesive composite resin. When the dental curing composition is a dental cement, the dental cement is also suitable as a dental self-adhesive cement. The dental curing composition can be used in one-component or two-component form as needed. When the dental curing composition is a two-component type, the content of each component described herein refers to the content after mixing the two components.

[0140] <Examples of composition of dental curable compositions> Next, suitable composition examples of the dental curable compositions according to their intended use are shown.

[0141] (Example of composition of dental filling composite resin) When the dental curable composition is a dental filling composite resin, the dental filling composite resin is not particularly limited, but preferably contains a polymerization initiator (A), a hydrophobic monomer without acidic groups (B-2-1), an organic amine compound (C), and a filler (E). The content of each component in the dental filling composite resin can be adjusted according to the balance of mechanical strength, aesthetics, and curability of the cured product, but an example of a suitable composition ratio is shown. Preferably, the content of each component in the dental filling composite resin is such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 0.001 to 3 parts by mass of polymerization initiator (A), 0.001 to 5 parts by mass of organic amine compound (C), 4 to 98% by mass of hydrophobic monomers (B-2-1) without acidic groups in the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition, and 40 to 90% by mass of filler (E) in the total 100% by mass of the dental curable composition. The content of each component in the aforementioned dental filling composite resin is preferably such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 0.005 to 1 part by mass of polymerization initiator (A), 0.01 to 3 parts by mass of organic amine compound (C), 8 to 95% by mass of hydrophobic monomers (B-2-1) without acidic groups in the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition, and 50 to 85% by mass of filler (E) in the total 100% by mass of the dental curable composition. The content of each component in the aforementioned dental filling composite resin is preferably such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 0.01 to 0.5 parts by mass of polymerization initiator (A) and 0.03 to 1 part by mass of organic amine compound (C), and more preferably contains 15 to 92% by mass of hydrophobic monomers (B-2-1) without acidic groups in 100% by mass of the total polymerizable monomers (B) contained in the dental curable composition, and contains 60 to 80% by mass of filler (E) in 100% by mass of the total dental curable composition. The dental curable composition used as the dental filling composite resin does not have to contain hydrophilic monomers (B-2-2).

[0142] (Example of composition of dental self-adhesive composite resin) When the dental filling composite resin is a dental self-adhesive composite resin, the dental self-adhesive composite resin is not particularly limited, but preferably contains a polymerization initiator (A), a hydrophobic monomer without acidic groups (B-2-1), a polymerizable monomer with acidic groups (B-1), an organic amine compound (C), and a filler (E). The content of each component in the dental self-adhesive composite resin can be adjusted according to the balance of adhesive strength to dentin, mechanical strength of the cured product, curability, etc., but an example of a suitable composition ratio is shown. Preferably, the content of each component in the dental self-adhesive composite resin is such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 0.001 to 3 parts by mass of polymerization initiator (A) and 0.001 to 5 parts by mass of organic amine compound (C), and of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 4 to 98% by mass of hydrophobic monomers (B-2-1) that do not have acidic groups and 0.5 to 40% by mass of polymerizable monomers (B-1) that have acidic groups, and of the total 100% by mass of the dental curable composition, it contains 40 to 90% by mass of filler (E). The content of each component in the aforementioned self-adhesive dental composite resin is preferably such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 0.005 to 1 part by mass of polymerization initiator (A) and 0.01 to 3 parts by mass of organic amine compound (C), and of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 8 to 95% by mass of hydrophobic monomers (B-2-1) that do not have acidic groups and 1 to 30% by mass of polymerizable monomers (B-1) that have acidic groups, and of the total 100% by mass of the dental curable composition, it contains 50 to 85% by mass of filler (E).The content of each component in the self-adhesive dental composite resin is preferably such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental curable composition, the polymerization initiator (A) is 0.01 to 0.5 parts by mass, and the organic amine compound (C) is 0.03 to 1 part by mass; of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition, the composition contains 15 to 92% by mass of hydrophobic monomers (B-2-1) without acidic groups and 2 to 20% by mass of polymerizable monomers (B-1) having acidic groups; and of the total 100% by mass of the dental curable composition, the composition contains 60 to 80% by mass of filler (E). The dental curable composition used as the self-adhesive dental composite resin does not have to contain hydrophilic monomers (B-2-2).

[0143] (Example of composition of dental bonding material) When the dental curable composition is a dental bonding material, the dental bonding material is not particularly limited, but preferably contains a polymerizable compound (A), a hydrophobic monomer without an acidic group (B-2-1), a hydrophilic monomer without an acidic group (B-2-2), a polymerizable monomer with an acidic group (B-1), an organic amine compound (C), and a filler (E). The content of each component in the dental bonding material can be adjusted according to the balance of adhesive strength to dentin, mechanical strength of the cured product, and curability, but an example of a suitable composition ratio is shown. Preferably, the content of each component in the dental bonding material is such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 0.1 to 10 parts by mass of polymerization initiator (A) and 0.1 to 20 parts by mass of organic amine compound (C), and of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 4 to 98% by mass of hydrophobic monomers (B-2-1) without acidic groups, 0.1 to 94% by mass of hydrophilic monomers (B-2-2) without acidic groups, and 0.5 to 40% by mass of polymerizable monomers (B-1) having acidic groups, and of the total 100% by mass of the dental curable composition, it contains 1 to 20% by mass of filler (E). The content of each component in the dental bonding material is preferably such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 0.3 to 5 parts by mass of polymerization initiator (A) and 0.5 to 15 parts by mass of organic amine compound (C), and of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 8 to 95% by mass of hydrophobic monomers (B-2-1) without acidic groups, 0.5 to 50% by mass of hydrophilic monomers (B-2-2) without acidic groups, and 1 to 30% by mass of polymerizable monomers (B-1) having acidic groups, and of the total 100% by mass of the dental curable composition, it contains 2 to 10% by mass of filler (E).The content of each component in the dental bonding material is preferably such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 0.4 to 4 parts by mass of polymerization initiator (A) and 1 to 10 parts by mass of organic amine compound (C), and of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 15 to 92% by mass of hydrophobic monomers (B-2-1) without acidic groups, 1 to 35% by mass of hydrophilic monomers (B-2-2) without acidic groups, and 2 to 20% by mass of polymerizable monomers (B-1) having acidic groups, and of the total 100% by mass of the dental curable composition, it contains 3 to 6% by mass of filler (E). The content of each component in the dental bonding material is preferably such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 0.5 to 3 parts by mass of polymerization initiator (A) and 1 to 10 parts by mass of organic amine compound (C), and of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 15 to 92% by mass of hydrophobic monomers (B-2-1) without acidic groups, 1 to 35% by mass of hydrophilic monomers (B-2-2) without acidic groups, and 2 to 20% by mass of polymerizable monomers (B-1) having acidic groups, and of the total 100% by mass of the dental curable composition, it contains 3 to 6% by mass of filler (E).

[0144] (Example of composition of dental cement) When the dental hardening composition is dental cement, the dental cement is not particularly limited, but preferably contains a polymerizable compound (A), a hydrophobic monomer without acidic groups (B-2-1), a hydrophilic monomer without acidic groups (B-2-2), a polymerizable monomer with acidic groups (B-1), an organic amine compound (C), and a filler (E). The content of each component in the dental cement can be adjusted according to the balance of adhesive strength to dentin, mechanical strength of the hardened product, hardening properties, etc., but an example of a suitable composition ratio is shown. Preferably, the content of each component in the dental cement is such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 0.001 to 3 parts by mass of polymerization initiator (A) and 0.001 to 5 parts by mass of organic amine compound (C), and of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 4 to 98% by mass of hydrophobic monomers (B-2-1) without acidic groups, 0.1 to 94% by mass of hydrophilic monomers (B-2-2) without acidic groups, and 0.5 to 40% by mass of polymerizable monomers (B-1) having acidic groups, and of the total 100% by mass of the dental curable composition, it contains 40 to 90% by mass of filler (E). The content of each component in the dental cement is preferably such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 0.005 to 1 part by mass of polymerization initiator (A) and 0.01 to 3 parts by mass of organic amine compound (C), and of the total 100% by mass of polymerizable monomers (B) contained in the dental curable composition, it contains 8 to 95% by mass of hydrophobic monomers (B-2-1) without acidic groups, 0.5 to 50% by mass of hydrophilic monomers (B-2-2) without acidic groups, and 1 to 30% by mass of polymerizable monomers (B-1) having acidic groups, and of the total 100% by mass of the dental curable composition, it contains 50 to 85% by mass of filler (E).The content of each component in the dental cement is preferably such that, per 100 parts by mass of polymerizable monomers (B) contained in the dental hardening composition, it contains 0.01 to 0.5 parts by mass of polymerization initiator (A) and 0.03 to 1 part by mass of organic amine compound (C), and of the total 100% by mass of polymerizable monomers (B) contained in the dental hardening composition, it contains 15 to 92% by mass of hydrophobic monomers (B-2-1) without acidic groups, 1 to 35% by mass of hydrophilic monomers (B-2-2) without acidic groups, and 2 to 20% by mass of polymerizable monomers (B-1) having acidic groups, and of the total 100% by mass of the dental hardening composition, it contains 60 to 80% by mass of filler (E). The dental composition used as the dental cement does not have to contain hydrophilic monomers (B-2-2). When used as a dental cement of the type that uses a pretreatment material, the dental hardening composition does not need to contain a polymerizable monomer (B-1) having an acidic group.

[0145] <Method for producing a dental curable composition> The dental curable composition can be easily produced by blending and mixing a polymerization initiator (A) and optional components in a manner known to those skilled in the art.

[0146] The present invention will be described in detail below with reference to examples and comparative examples, but the present invention is not limited to the examples.

[0147] The components of the dental curable compositions in the examples and comparative examples are listed below, along with their abbreviations.

[0148] [Polymerization Initiator (A)] a-1: Compound represented by the following formula (8) (manufactured by Fujifilm Wako Pure Chemical Industries, Ltd.)

[0149] [Polymerization initiator (A')] BAPO: Bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide CQ-1: Compound represented by the following formula (10)

[0150] CQ-2: Compound represented by the following formula (11)

[0151] Cu: Copper II acetate, BPB: Tert-butyl peroxybenzoate, KPS: Potassium persulfate

[0152] [Polymerizable monomer (B)] <Polymerizable monomer with acidic group (B-1)> MDP: 10-methacryloyloxydecyldihydrogenphosphate

[0153] <Polymerizable monomers without acidic groups (B-2)> (Hydrophobic monomers (B-2-1)) Bis-GMA: Bisphenol A di(2-hydroxypropoxy) dimethacrylate (also known as: 2,2-bis[4-(2-hydroxy-3-methacryloyloxypropoxy)phenyl]propane) MAEA: N-methacryloyloxyethyl acrylamide D-2.6E: 2,2-bis(4-methacryloyloxypolyethoxyphenyl)propane (average number of moles of ethoxy groups added: 2.6) DD: 1,10-decanediol dimethacrylate 11-MUS: 11-methacryloyloxyundecyltrimethoxysilane (Hydrophilic monomers (B-2-2)) HEMA: 2-hydroxyethyl methacrylate DEAA: N,N-diethyl acrylamide

[0154] [Organic amine compounds (C)] PDE: 4-(N,N-dimethylamino)ethyl benzoate DEPT: N,N-bis(2-hydroxyethyl)-p-toluidine

[0155] [Polymerization accelerator (D)] TPSS: 2,4,6-triisopropylbenzenesulfinate sodium BTA: 1H-benzotriazole NAA: sodium sulfite

[0156] [Filler (E)] E-1: Fine particle silica "Aerosil® R972" manufactured by Nippon Aerosil Co., Ltd., average primary particle size (manufacturer's catalog value): 16 nm E-2: Barium glass E-3: Silane-treated barium glass powder prepared by the following method (Method for preparing silane-treated barium glass powder) Barium glass (manufactured by ESSTECH, product code "Raysolb E-3000") was crushed in a ball mill to obtain barium glass powder with an average particle size of approximately 2.4 μm. 100 parts by mass of this barium glass powder was surface-treated by a conventional method, that is, by dispersing the barium glass powder in a solution containing 3 parts by mass of hydrolyzed 3-methacryloyloxypropyltrimethoxysilane to obtain silane-treated barium glass powder.

[0157] E-4: Alumina, manufactured by Nippon Aerosil Co., Ltd., product name "AEROXIDE® Alu C", average primary particle size (manufacturer's catalog value): 20 nm E-5: Silane-treated silica powder prepared by the following method, refractive index: 1.55 (Method for preparing silane-treated silica powder) Silica powder (quartz, manufactured by Nichitsu Co., Ltd., product name: High Silica) was crushed in a ball mill to obtain crushed silica powder. The average primary particle size of the obtained crushed silica powder was measured by volume using a laser diffraction particle size distribution analyzer (manufactured by Shimadzu Corporation, model "SALD®-2300") and was found to be 2.2 μm. Surface treatment was performed on 100 parts by mass of this crushed silica powder by a conventional method, that is, by dispersing the crushed silica powder in a solution containing 4 parts by mass of hydrolyzed γ-methacryloyloxypropyltrimethoxysilane to obtain silane-treated silica powder.

[0158] [Solvent] Purified water, ethanol

[0159] [Additive] BHT: 3,5-di-tert-butyl-4-hydroxytoluene (polymerization inhibitor)

[0160] [Preparation and Evaluation of Dental Curable Compositions] <Examples 1-4 and Comparative Examples 1-6> Dental curable compositions for each example and comparative example were prepared by mixing each material according to the formulations described in each table. Then, the tensile adhesive strength to dentin was measured using each prepared dental curable composition according to the following procedure. The results are shown in Tables 1-3.

[0161] <Method for measuring tensile adhesive strength to dentin> (1) A smooth surface was formed by polishing the labial dentin of a bovine tooth, which was to be used as the substrate for forming the surface to be measured, with silicon carbide paper (#1000), and ultrasonic cleaning was performed for 5 minutes. The smooth surface after cleaning was used as the surface to be measured for adhesive strength. Next, an adhesive tape (thickness approximately 150 μm) with a circular hole of 3 mm in diameter was applied to the surface to be measured to define the adhesive area between the surface to be measured and the dental hardening composition to be measured.

[0162] (2) Preparation of test specimens for adhesion testing Next, test specimens for adhesion testing were prepared using the dental curable compositions obtained in each example and comparative example. The method for preparing the test specimens is as follows.

[0163] - Dental curable compositions obtained in Examples 1-2 and Comparative Examples 1-2 (Table 1) Each dental curable composition was applied to the circular holes of the adhesive tape on the measurement target surface using an applicator brush, and then dried by air blowing. Next, the applied dental curable composition was cured by irradiating it with light for 10 seconds using a dental polymerization light curing lamp (manufactured by ULTRADENT JAPAN Co., Ltd., product name "VALO® Curing Light"). Next, dental filling composite resin (manufactured by Kuraray Noritake Dental Co., Ltd., product name "Clearfil® AP-X") was supplied onto the surface of the cured dental curable composition in the circular holes, and the dental filling composite resin was filled into the circular holes. Next, the surface of the filled dental filling composite resin was covered with a release film (polyester), and the coated surface of the dental filling composite resin was smoothed by placing a slide glass on the release film and pressing it down. Next, the dental composite resin for fillings was cured by irradiating it with light for 20 seconds using a dental polymerization light curing unit (ULTRADENT JAPAN Co., Ltd., product name "VALO® Curing Light") via the release film. After that, the release film was peeled off from the surface of the cured dental composite resin. A test specimen for adhesion testing was prepared by bonding one end face (circular cross-section) of a stainless steel cylindrical rod (7 mm in diameter, 2.5 cm in length) to the exposed surface of the cured dental composite resin using commercially available dental resin cement (Kuraray Noritake Dental Co., Ltd., product name "SA Routing® Multi"). The obtained test specimen was left to stand for 30 minutes in an environment controlled at 15-35°C, and then immersed in distilled water. Test specimens immersed in distilled water were left standing for 24 hours in a constant temperature chamber maintained at 37°C, and these were used to measure adhesive strength.

[0164] - Dental curable compositions obtained in Example 3 and Comparative Examples 3-4 (Table 2) A paste made by mixing equal weights of the first and second components of each dental curable composition was built up in the circular holes of the adhesive tape on the surface to be measured, and the surface of the built-up dental curable composition was covered with a release film (polyester). Next, a glass slide was placed on the release film and pressed down to smooth the built-up surface of the dental curable composition. Subsequently, the dental curable composition was cured by irradiating it with light for 10 seconds using a dental polymerization light curing light (manufactured by ULTRADENT JAPAN Co., Ltd., product name "VALO® Curing Light") through the release film. After that, the release film was peeled off from the surface of the cured dental curable composition. For the adhesion test, one end face (circular cross-section) of a stainless steel cylindrical rod (7 mm in diameter, 2.5 cm in length) was bonded to the surface of the hardened dental hardening composition using commercially available dental resin cement (manufactured by Kuraray Noritake Dental Co., Ltd., product name "SA Routing® Multi"). The resulting test specimens were left to stand at 25°C for 30 minutes, and then immersed in distilled water. The test specimens immersed in distilled water were then left in a constant temperature chamber maintained at 37°C for 24 hours, and these specimens were used to measure the adhesion strength.

[0165] - Dental curable compositions obtained in Example 4 and Comparative Examples 5-6 (Table 3) Each dental curable composition was filled into the circular holes of the adhesive tape on the surface to be measured, and the surface of the filled dental curable composition was covered with a release film (polyester). Next, a glass slide was placed on the release film and pressed down to smooth the coated surface of the dental curable composition. Subsequently, the dental curable composition was cured by irradiating it with light for 10 seconds using a dental polymerization light curing device (ULTRADENT JAPAN Co., Ltd., product name "VALO® Curing Light") through the release film. After that, the release film was peeled off from the surface of the cured dental curable composition. For the adhesion test, one end face (circular cross-section) of a stainless steel cylindrical rod (7 mm in diameter, 2.5 cm in length) was bonded to the surface of the hardened material using commercially available dental resin cement (manufactured by Kuraray Noritake Dental Co., Ltd., product name "SA Routing® Multi"). The resulting test specimens were left to stand at 25°C for 30 minutes, and then immersed in distilled water. The test specimens immersed in distilled water were left in a constant temperature chamber maintained at 37°C for 24 hours, and these specimens were used to measure the adhesion strength.

[0166] (3) Measurement of adhesive strength The tensile adhesive strength of the test specimens obtained for the adhesive test above was measured using a universal testing machine (Shimadzu Corporation, Autograph® "AG-I 100kN") at a crosshead speed of 2 mm / min in an environment controlled at 15 to 35°C. Measurement values ​​were obtained for three test specimens for each curable composition, and the average values ​​are shown in each table.

[0167]

[0168] As shown in Table 1, the dental curable compositions of Examples 1 and 2 exhibited superior tensile adhesion strength to dentin compared to the dental curable compositions of Comparative Examples 1 and 2.

[0169]

[0170] As shown in Table 2, the dental curable composition of Example 3 exhibited superior adhesive strength to dentin compared to the dental curable compositions of Comparative Examples 3 and 4.

[0171]

[0172] As shown in Table 3, the dental curable composition of Example 4 exhibited superior adhesive strength to dentin compared to the dental curable compositions of Comparative Examples 5 and 6.

[0173] The dental hardening composition according to the present invention exhibits excellent adhesive strength to dentin, and can therefore be suitably used as a dental bonding material, a dental filling composite resin, a dental cement, a dental self-adhesive cement, or a dental self-adhesive composite resin.

Claims

1. A dental curable composition comprising a polymerization initiator (A) and a polymerizable monomer (B) represented by the following general formula (1). (In the formula, R 1 ~R 8 Each of these is an organic group (s1) containing a hydrogen atom, a linear or branched alkyl group having 1 to 20 carbon atoms, a linear or branched alkoxy group having 1 to 20 carbon atoms, a halogen atom, or a site to which two or more carbon atoms are linearly bonded and two or more hydroxyl groups, R 1 ~R 8 Of these, at least one is an organic group (s1) containing a site where two or more carbon atoms are bonded in a linear chain and two or more hydroxyl groups.

2. R in the general formula (1) 1 However, the organic group (s1) is R 2 ~R 8 The dental curable composition according to claim 1, wherein each is independently a hydrogen atom, a linear or branched alkyl group having 1 to 20 carbon atoms, a linear or branched alkoxy group having 1 to 20 carbon atoms, or a halogen atom.

3. The dental curable composition according to claim 2, wherein the polymerization initiator (A) is a compound represented by the following general formula (2). (In the formula, R 1a This is an organic group (s1) containing a site where two or more carbon atoms are bonded in a linear chain and two or more hydroxyl groups.

4. The dental curable composition according to any one of claims 1 to 3, wherein the organic group (s1) is represented by the following general formula (3). (In the formula, X is -C(=O)-O-, -C(=O)-NH-, or -C(=O)-. Y is a group containing a hydrocarbon group (s2) having 2 to 20 carbon atoms and two or more hydroxyl groups. * indicates a bonding site.) 5. The curable dental composition according to claim 4, wherein the organic group (s1) is a group represented by the following general formula (4-1). (In the formula, n 1 is an integer of 1 to 10. * represents a bonding site.) 6. The dental curable composition according to any one of claims 1 to 3, wherein the organic group (s1) is a group comprising a five-membered ring having two or more hydroxyl groups or a six-membered ring structure having two or more hydroxyl groups.

7. The dental curable composition according to claim 6, wherein the group comprising a five-membered ring having two or more hydroxyl groups or a six-membered ring structure having two or more hydroxyl groups is a group represented by the following general formula (5-1). (In the formula, n 1 (where * is an integer between 1 and 10. * indicates a connection point.) 8. The dental curable composition according to any one of claims 1 to 3, wherein the polymerizable monomer (B) comprises a bifunctional monomer.

9. The dental curable composition according to any one of claims 1 to 3, wherein the polymerizable monomer (B) comprises a polymerizable monomer (B-1) having an acidic group.

10. A dental curable composition according to any one of claims 1 to 3, further comprising an organic amine compound (C).

11. A dental curable composition according to any one of claims 1 to 3, which is a dental bonding material, a dental filling composite resin, or a dental cement.

12. The dental curing composition according to claim 11, wherein the dental filling composite resin is a dental self-adhesive composite resin and the dental cement is a dental self-adhesive cement.